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Abstract 
STEROID ANALYSIS BY PH-MEDIATED 
STACKING MEKC 
by Liliya Bykova 
This dissertation is based on research that led to the development and application of capillary 
electrophoresis method for the analysis of sex steroid hormones in the blood or plasma of fish 
species. The analysis of steroid hormones is essential to reveal chemical compounds that are 
suspected in endocrine disruption, but it is challenging due to the similarity of the chemical 
structures of steroids, their low concentrations, and limited volumes of plasma or blood samples in 
fish available for analysis. There is therefore an acute need to develop reliable accurate and 
systematic analytical methods applicable for the analysis of structurally similar steroid hormones at 
very low concentrations. The method developed here is based on micellar electrokinetic 
chromatography, a type of capillary electrophoresis that incorporates secondary equilibria.  The 
method utilizes pH-stacking for steroid preconcentration to improve the detection limits. This 
method of pH-stacking is accomplished by using charged derivatives of cyclodextrin which 
become neutral (protonated) or anionic (deprotonated) based on the pH of the sample buffer. 
Preconcentration by means of pH-stacking occurs upon introduction of the sample into the 
capillary at the pH junction, resulting in a fast and efficient separation analysis of steroids. Using 
the developed method the separation of eight targeted steroids, that include α,β-
dihydroxyprogesterone, ethynylestradiol, 17β-estradiol, estrone, hydroxyprogesterone, 11-
ketotestosterone, progesterone, and testosterone is achieved in less than 4 min which is 
substantially faster than steroid analysis by immunoassay, GC-MS or LC-MS. For all targeted 
steroids, the within-day and day-to-day reproducibility in migration time is <1 and <2 % relative 
standard deviation (RSD), respectively.  The reproducibility in peak area obtained in aqueous 
samples is below 6 % and 22 % (RSD) within-day and day-to-day respectively. The limits of 
detection range from 2 to 14 nM using a 60 s electrokinetic injection. The method is validated by 
measuring the recovery of standard steroids added to the aqueous or fish plasma samples prior to 
sample preparation. The recovery of testosterone and 17β-estradiol added to the fish plasma prior 
to sample preparation range from 74 % to 102 %. The method is successfully applied to the 
 
determination of sex steroid levels in blood plasma of yellow perch captured from natural aqueous 
habitats. The results are compared to radioimmunoassay.   
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Rapid separation methods, such as capillary electrophoresis, are effective tools for screening the 
chemical composition of a wide variety of samples constituents. The following chapters describe 
the development of an effective analytical method for steroid analysis using capillary 
electrophoresis. Chapter 1 provides the literature background of endocrine disruption and discusses 
several known analytical methods used for steroid analyses. Chapter 2 proceeds with a detailed 
account of capillary electrophoresis, and describes the method developed in this work which is 
based on the micellar electrokinetic capillary chromatography (MEKC). Chapter 3 is devoted to 
in-capillary preconcentration methods, and much of the data in Chapter 3 is published in 
reference [1]. Chapter 3 includes a comparison of chromatographic preconcentration and pH-
stacking preconcentration using charged cyclodextrin. The comparison indicates the latter 
technique is much more reproducible for the targeted analysis. The method is evaluated using six 
representative steroid hormones. The limits of detection were measured and stacking 
enhancement factor was calculated and compared to the steroid analysis at non-stacking 
conditions. Finally, Chapter 4 presents the application of the stacking-MEKC method to the 
analysis of steroids in fish blood or plasma samples. Data from this chapter comprises a 
manuscript in preparation. The flushing protocol used to regenerate the inner surface of the 
capillary in analysis of standard steroid samples needed to be modified in order to achieve 
reproducible results when used for plasma sample extracts. The analysis of the plasma samples 
required the development of an effective purification scheme to extract steroids while 
eliminating interfering compounds. The method was validated by recovering steroids spiked in 
the aqueous standard steroid solutions and in the fish plasma samples prior to extraction. To 
2 
 
investigate the effect of the differences among the fish species on the stacking, four different fish 
species were used for analysis. The developed and optimized method was applied to the 
determination of steroids in plasma of yellow perch fish. The MEKC results were compared to 
the results independently measured by radioimmunoassay.  The developed method allowed for 
determination of the steroids in plasma samples with the improved limits of detection obtained 




C H A P T E R  1   
B A C K G R O U N D   A N D   S I G N I F I C A N C E   O F    
E N D O C R I N E   D I S R U P T I O N 
 4
1.1. PHENOMENON OF ENDOCRINE DISRUPTION 
1.1.1. INTRODUCTION  
The scientific interest in the occurrence of endocrine disruption dates back to the 
sixties and early seventies, when it was first repoted that a synthetic estrogen, 
diethylstilbestrol, can have adverse effects on experimental animals and even humans (2).
The pioneering work of John McLachlan, Howard Bern and other researchers has paved 
the way to the present field of endocrine disruption (3-6). However, the broad scientific 
and social recognition of the endocrine disruption problem was due to the work of Theo 
Colborn in the early nineties who found the evidence that certain non-hormone chemicals 
may also affect the sexual development of numerous wildlife species (7).  
It is now known that a variety of environmental horm nes and chemical pollutants 
in the environment disrupt human reproduction causing birth defects, sexual abnormalities, 
and reproductive failure. The threat of changes in the animal or human endocrine system 
by xenobiotic compounds (chemicals which are not normally produced or likely to be 
present in an organism but which are found in it) has become a major issue facing 
researchers today and continues to be a central topic at toxicological conferences, in the 
general press, as well as in the political arena (8). In particular, the problem of endocrine 
disruption has affected the state of West Virginia. In 2004, the researchers at the USGS 
(U.S. Geological Survey) reported 80 % of the male bass fish collected from the South 
Branch of the Potomac River (Hardy County, WV) had female tissue developed inside 
their gonodal tissue (9-12). Smallmouth bass are valued game fish in much of t e United 
States and a high occurrence of testicular oocytes (intersex) has gained great public 
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attention (13, 14). Endocrine disrupting chemicals have been identifi d in some areas of 
the Potomac Watershed, and it is suspected that they are contributing to these occurrences 
(15, 16).   
1.1.2. ENDOCRINE DISRUPTION, SOURCES AND CONSEQUENCES 
An endocrine disrupting compound (EDC) is a chemical compound that can 
potentially disturb the normal communication between the hormone and the cell receptor in 
the living organism, leading to the malfunctioning metabolism or catabolism of sex 
steroids, suppressed fertility and reproduction, and even complete sex-reversal in the 
organism itself or its next generation (17).  
Among the significant sources of endocrine active chemicals affecting the 
environment are the agricultural waste products, atmospheric contamination, and sewage 
(18-20). The number of registered and potential endocrine d sruptors is constantly growing. 
These include alkylphenols (21), heavy metals (22), pesticides (23), phthalates (24, 25), 
polycyclic aromatic hydrocarbons (PAHs) and dioxin (26), polychlorinated biphenyls 
(PCBs) (27, 28), natural and synthetic steroid estrogens (29), and pharmaceutical drugs 
(30-32).  
All stages of the hormonal function of an organism can be affected including 
hormone synthesis, storage/release, transport/clearance, receptor recognition/binding, and 
post-receptor responses.  The effects may be reversible or irreversible, immediate or 
latent. The intensity of the exposure depends on may f ctors including the dose of the 
pollutant, the interval of exposure, the body weight, stage of development etc. This 
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complexity creates unique challenges in the detection and measurement of endocrine 
disruptors in the environment. 
1.1.3. THE NEED FOR BIOMONITORS 
The aquatic environment is exceptionally subject to xenobiotic damage. Water and 
sediment can act as a sink for many types of polluti n from multiple sources. The 
pollutants can be retained in the sediments and subseq ently absorbed into the aquatic 
organisms. To determine the safe maximum contaminant level in the environment one has 
to measure the rate of accumulation of pollutants by the aquatic organisms, explore the 
biochemical disruption mechanism and estimate the possibility of disruptions in the 
viability or fertility of the organisms and their offspring.  
Biomonitoring is generally achieved by placing an animal into the test water 
containing a suspect chemical and observing its effects on the animal. A simple toxicity 
measure is the dose of a pollutant which kills 50 % of the test animals (LD50) (33). 
Laboratory toxicity tests commonly inspect the effects of a single pollutant for a 
relatively short period of time under controlled conditions. Exploring similar effects in 
the wildlife is equally important since the organisms are exposed to lower levels of 
complex mixtures, but over much longer time scales.  
Fish accumulate pollutants in their fatty tissues such as liver and gonads, but the 
effects may become apparent only when concentrations in such tissues reach threshold 
level after several years. Thus the fish is a natural long-term biomonitor.  
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1.1.4. ENDOCRINE SYSTEM 
The endocrine system is the chemical communication system of the body 
comprising many glands such as ovaries, testes, pancreas, adrenal, thyroid, and parathyroid. 
The signals from the brain resulting from the external stimuli are modulated by the 
hypothalamic-pituitary system as changes in the hormone secretion. The hypothalamus 
produces gonadotropin releasing hormone which causes further release of gonadotropin 
from the pituitary gland. Gonadotropin is a peptide hormone that acts on the glands to 
stimulate secretion of sex steroid hormones and is the most concern in the context of 
reproduction. The secreted steroids in turn initiate changes in the secondary sexual 
characteristics, behavior, courtship, development and maturation of the gamets, and 
spawning (Fig. 1.1).  
The endocrine signaling cascades similar to that in Figure 1.1 provide several 
sites where the endocrine signal can be regulated. For example, testosterone is secreted 
by the testis but regulates its own secretion by acting upstream at the pituitary gland and 
hypothalamic gland. Peptide hormones are commonly the intermediate messengers along 
a signaling cascade, while the terminal hormone is often of nonpeptide origin (i.e., 
steroids). Toxicologically the function of the terminal hormones appears to be most at 
risk of chemical disruption, where the foreign molecul s bind to the nuclear receptors of 
these hormones in an agonistic or antagonistic manner (Section 1.1.6). The binding of a 
xenobiotic substance to the receptor results in abnormal receptor function with the 
associated toxicological outcome.  
Steroid hormones are lipophilic in nature and can be transferred in the circulatory 
system from their point of origin to their target tissues only by specific carrier proteins 
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such as sex hormone-binding globulin, corticosteroid-binding globulin, thyroxine-binding 
globulin (transthyretin), and albumin. Sex hormone-binding globulin (SHBG) binds 
testosterone, 17β-estradiol, and other sex steroids. Most steroid and thyroid hormones (> 
95 %) are reversibly bound to proteins in the blood. Upon dissociation from the proteins, 
the steroid hormones can cross the cell membrane via diffusion due to their lipophilicity. 
Therefore, the vitally critical parameter is not the total hormone concentration in the 
plasma, but that of a free, unbound steroid.  
The molecular mechanism of steroid receptor action described by Nelson and Cox 
(34) occurs as follows: after crossing the membrane of the target cell, the hormone binds 
to specific receptor proteins in the nucleus. The steroid hormone receptors (SHR) include 
the glucocorticoid, mineralcorticoid, progesterone, androgen, and estrogen receptors. The 
estrogen receptor is the major regulatory unit within e estrogen-signaling pathway. When 
functioning normally, the hormone binding changes the conformation of the receptor 
protein. It forms homo- or hetero-dimers with other o mone receptor complexes and binds 
to specific regulatory regions, called hormone respon e elements, in the DNA adjacent to 
specific genes. The binding regulates the transcription of the adjacent gene(s), increasing or 
decreasing the rate of the formation of mRNA. The hormone-regulated gene thus produces 
the specific cellular response to the hormone.  
The bodily functions regulated by the endocrine system include reproduction, 
energy production, metabolism, fetal development, growth, and maturation. For example, 
ovaries release estrogen, which is necessary for grwth, fetal development, and 
reproduction. The thyroid affects metabolism and brain development, and the pituitary 
controls other glands in the endocrine system. The endocrine system is very sensitive to 
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very low levels of pollutants. Any anthropogenic sub tance, a substance caused by human 
activity, can potentially interfere with any of the steps described above to cause a 
disruption of the endocrine system.  
 
 
Figure 1.1. Endocrine signaling cascade of the reproductive system in the fish. (GnRH – gonadotropin 
releasing hormone, GtH – gonadotropin, E2 – 17β-estradiol, T – testosterone, 11KT – 11-ketotesteoster ne, 
17,20βDHP – dihydroxyprogesterone). Reproduced with kind permission of Springer Sciences from (35). 
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1.1.5. STEROID HORMONES  
The major difference between the endocrine system of the fish and the mammals 
are the steroid hormones. The main steroids in teleost fish, a large group of fishes with 
bony skeletons, their interrelationship via biosynthesis and the major enzymes are shown in 
Figure 1.2. The chemical structures of these steroids can be found in Table A1, Appendix 
1.   
  
 
Figure 1.2. Schematic demonstration of steroid biosynthesis in teleost fish (for simplicity only major 
pathways are shown). Reproduced with kind permission of Springer Sciences from (35).  
Steroids are oxidized derivatives of sterols. They ave the sterol nucleus but lack 
of alkyl chain attached to ring D of cholesterol, and they are more polar than cholesterol, 
for which the logarithm of the partition coefficient (log P) is 9.9. A steroid hormone 
molecule consists of a tetracyclic ring structure with substituents at specific sites within the 
molecule (Fig. 1.3.). The substituents are usually hydroxyl, carbonyl and alkyl groups. 
 11
Very often steroids and their metabolites differ only by the presence or absence of one 



























Figure 1.3. Basic structure of a steroid molecule. 
 
 
The biosynthesis of steroid hormones starts from a common precursor, cholesterol, 
and proceeds via a complex sequence of biochemical reactions (Fig. 1.2). Kime (35) 
describes this process quite nicely, and briefly, cholesterol is converted to pregnenolone by 
the cholesterol side-chain cleavage enzyme (P450scc). Pregnenolone is then oxidized at 
position C-3 by 3β-hydroxysteroid dehydrogenases/∆5-∆4 isomerases (3β-HSDs) producing 
progesterone. The 17α-hydroxylation of progesterone by 17α-hydroxylase/C17-20 lyase 
(P450c17) results in the formation of 17-hydroxyprogesterone. 17-hydroxyprogesterone is 
further converted to androstenedione by the lyase activity of P450c17. The final steps of 
estrogen production are controlled by P450arom and 17HSDs. Aromatase catalyzes the 
aromatization of the androgens to estrogens, such as androstenedione to estrone or 
testosterone to estradiol (36), whereas 17β-HSDs are responsible for the interconversion 
between 17-ketosteroids, like androstenedione and estrone, and 17β-hydroxysteroids, e.g. 
testosterone and estradiol (37). Finally testosterone is converted to 11-ketoteststerone. In 
teleost fish, 11-ketotestosterone is important for sexual differentiation and male sexual 
development (38). 
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All steroid hormones act through nuclear receptors to change the level of 
expression of specific genes. Because hormones havevery high affinity for their 
receptors, very low concentrations of hormones (nanomolar or less) are sufficient to 
produce responses in the target tissues of the fish. The exposure to hormonally active 
compounds does not necessarily lead to adverse effects. Sorting out adverse effects of 
endocrine disruptors is a scientific challenge but it is also practically important, since 
exposure to such compounds through food, air, water and many household products is 
everywhere and unavoidable. Therefore, in order to better identify the biological 
disruption, key steroids in the endocrine cycle must be profiled. 
1.1.6. DISRUPTION OF HORMONAL REGULATION BY EXOGENOUS COMPOUNDS 
The structural requirements and mechanisms of action of endocrine disruptors are 
complicated by the fact that there exist multiple ways to interfere with the endocrine 
system. The predominant mechanisms of disruption of hormone activity by xenobiotics 
involve: (1) mimicking steroids by binding to the rceptor and inducing (agonizing) or 
inhibiting (antagonizing) the steroid response; (2) modulating endogenous steroid 
hormone levels.  
To bind to the receptor, xenobiotics first compete with hormones for the binding 
to the carrier protein, which, as mentioned earlier, act as a vessel that distributes steroid 
hormones throughout the body. For example, xenobiotics estrogens can be both 
endogenous (from within an organism) which regulate the growth and development of their 
target tissues, e.g. estradiol, and exogenous (from outside of an organism) with estrogenic 
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and/or anti-estrogenic activities that induce or inhibit estrogenic response and may disrupt 
the regulatory pathways, e.g. ethynyl estradiol.  
1.1.6.1. Hormone Receptor Agonists 
A hormone receptor agonist is a compound that binds to and activates a hormone 
receptor. Endogenous hormones, for example 17β-estradiol and 5α-androstan-3α,17β-diol 
(commonly known as dihydrotestosterone), function as agonists to their respective 
receptors. Xenobiotics can act as receptor agonists and stimulate receptor-dependent 
physiological processes in the absence of the endogenous receptor ligand (hormone).  
The estrogen receptor is most susceptible to the agonistic action of xenobiotics 
due to their diverse molecular structures. Compounds which bind to the estrogen receptor 
and induce receptor-mediated response, are termed estrog ns or estrogen receptor agonists. 
Whether a xenobiotic can fit into the binding-pocket of the receptor and function as a 
receptor agonist is determined by the structure of the xenobiotic and its electrical charge. 
Some drugs are rather potent estrogens (i.e. diethylstilbestrol); however, chemicals with 
estrogenic activity are typically weak agonists with activity several orders of magnitude 
less than that of 17β-estradiol. However, adult males, young individuals, nd embryos all 
have been shown to exhibit endocrine toxicity resulting from xenoestrogen exposure due 
to the small amount of endogenous 17β-estradiol in these individuals (38). The 
physiological consequence of the xenoestrogenic activity is typically feminization, for 
example, breast development in males (gynecomastia) (39, 40). 
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1.1.6.2. Hormone Receptor Antagonists 
Receptor antagonists are chemicals that bind to a hormone receptor but do not 
activate it. These chemicals inhibit receptor activity by preventing the endogenous 
hormone from activating the receptor. Estrogen receptor antagonists include certain 
phytochemicals (i.e., flavonoids) and PCBs. Estrogen receptor antagonism typically leads 
to de-feminization. In laboratory animal studies, etrogen receptor antagonists have been 
shown to disrupt estrous cycles and damage fertility in females (41).  
Chemicals that known to bind to the androgen receptor in an antagonistic way 
include, for example, the heart failure drugs, spironolactone and cimetidine, and 
antiandrogen prostate cancer drugs, cyproterone acetate and hydroxyflutamide (42). 
Environmental chemicals that have been shown to act as androgen receptor antagonists 
include the metabolites of the agricultural fungicide vinclozolin, the DDT metabolite p, 
p'-DDE, some hydroxylated PCBs, and the organophosphate insecticide fenitrothion (43). 
Androgen receptor antagonism, unlike that of the estrogen receptor, may result in de-
masculinization.  
 1.1.6.3. Mixed Agonists/Antagonists  
Certain chemicals can function as either a receptor ag nist or antagonist, and are 
referred to as mixed agonists/antagonists. The particular function depends on the level of 
endogenous hormone in the organism, the concentration of the xenoagonist, the binding 
affinity of the xenoagonist to the receptor, the concentration of the endogenous, and the 
binding affinity of the endogenous hormone to the receptor. For example, a weak agonist 
may bind to a receptor and stimulate some low-level receptor-mediated activity in the 
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absence of the endogenous hormone. However, in the presence of the hormone, binding 
of the xenobiotic to the receptor may prevent the binding of the endogenous hormone and 
suppress the hormonal activity if the xenobiotic is a weaker activator.  
The drug tamoxifen functions as an estrogen receptor antagonist in reproductive 
tissue but functions as an agonist with respect to the preservation of bone mineral density 
and reducing serum cholesterol concentrations (44). Accordingly tamoxifen can function 
as a prophylactic against the growth of estrogen-responsive breast cancers and 
osteoporosis via two different mechanisms, estrogen receptor antagonism and agonism, 
respectively. 
1.1.6.4. Inhibitors of Hormone Synthesis 
Endocrine toxicants can cause antihormone activity by lowering the levels of the 
endogenous hormones in the body. With steroid hormones, chemicals typically elicit this 
effect by inhibiting the enzymes necessary for the synthesis of the hormone. For example, 
cytochrome P450 enzyme (CYP19) is responsible for the aromatization of testosterone to 
form 17β-estradiol. CYP19 inhibitors such as breast cancer treatment drugs, fadrozol, 
anastrozole, letrozole, can lower the endogenous 17β-estradiol levels resulting in de-
feminization (45). Cytochrome P450s enzymes are also critical to various hydroxylation 
reactions that contribute to the synthesis of androgens and other steroid hormones. 
Inhibition of these enzymes can result in a variety of antisteroid hormone effects. For 
example, the agricultural and medicinal fungicides propiconazole, ketoconazole, and 
fenarimol are capable of inhibiting P450 enzymes and reducing synthesis and circulating 
levels of testosterone and other steroid hormones. Toxicological consequences of the 
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lowering of the endogenous steroid hormone levels are typically comparable to the 
effects elicited by antagonists of the hormone’s receptor. 
1.2. LITERATURE METHODS FOR STEROID ANALYSIS 
1.2.1. INTRODUCTION 
Although the concentration of specific pollutants may be analyzed at very low 
levels, no single method can predict or detect all EDCs present in an environmental 
sample. Ultimately, this prevents the analysis of cmplex biological mechanisms of 
endocrine disruption in one simple test. To address this environmental problem, reliable 
analytical methods must combine several types of analysis including in vivo and in vitro 
bioassays, and analytical chemistry for the determination of structurally similar steroid 
hormones at very low concentrations. Monitoring the key steroid hormones in the 
endocrine cycle of fish is essential to provide insight into the complex metabolism 
involving steroid hormones and identify a biological disruption. Hormones can cause 
endocrine disruption at very low concentrations. For example, steroid estrogens can be 
harmful to the fish at a concentration as low as 2.0 ng/L (46). Profiling circulating steroids 
in biologically relevant concentrations to determine how EDCs affect the endocrine system 
thus requires highly sensitive analytical methods. The separation of steroid hormones is 
further complicated by the high hydrophobicity of steroid molecules and their similar 
chemical structures. Finally, the analysis of steroids in fish plasma is difficult due to the 
presence of interfering compounds and small amount f the fish blood plasma available.  
Natural and synthetic sex steroid hormones can be analyzed by liquid or gas 
chromatography coupled to mass spectrometry, immunoassay, or capillary electrophoresis. 
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A number of papers (47-60) reported the analysis of one or several steroids simultaneously 
present in water, urine, or sediments. There are few r reports dealing with the blood or 
plasma (61-88). A brief introduction to the benefits and limitatons of the available methods 
for steroid analysis is presented in the following sections. 
1.2.2. LC-MS AND GC-MS OF STEROIDS 
Natural and synthetic sex steroid hormones have been analyzed by liquid or gas 
chromatography coupled to mass spectrometry. Mass spectrometric detection allows for the 
structural elucidation of steroids and steroid metabolites, eliminating the need for 
predictive identification of steroids in the sample and enabling identification of steroid 
metabolites for which no immunoassay is available. Isotope-dilution GC-MS is a 
reference measurement procedure for plasma steroids listed in the database of the Joint 
Committee for Traceability in Laboratory Medicine (89). It has been widely used to 
validate immunoassays for steroid analysis as they require more thorough validation due 
to their cross reactivity (90). Despite isotope-dilution GC-MS being a de-facto g ld 
reference method for steroid analysis, isotope-dilution LC-MS/MS has been proven to 
demonstrate the same accuracy for steroid analysis (91, 92) and is also used by clinical 
laboratories for the analysis of steroid hormones. Both LC-MS and GC-MS provide very 
low detection limits for LC-MS (2.8 – 7.1⋅102 ng/L) (47-57, 61-71, 93) and GC-MS (1 – 
1.4⋅103 ng/L) (58, 59, 72-79). These methods cannot, however, be used for fast steroid 
profiling. It takes 20-45 min by LC-MS (48, 50, 54, 56, 57, 61-65, 93), and 14.5-35 min by 
GC-MS (58, 72-74) to obtain a steroid profile, excluding sample preparation time. This is a 
considerably long time, especially when several hundred analyses or large-scale screening 
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have to be performed. In addition, isotope-dilution methods require isotope labeled steroid 
standards which are expensive and not readily available for all the steroids of interest. 
Another shortcoming is the large sample injection vlumes required by chromatography. 
For example, a typical sample injection volume in LC-MS is 2 – 100 µL, and 1 – 2.5 µL in 
GC-MS. Additionally, liquid chromatography uses large volumes of flammable, expensive, 
and toxic mobile phases for analysis. While liquid chromatography does not require sample 
derivatization, gas chromatography method requires volatilization of the steroid analyte 
which can be obtained by derivatization of the analyte for 40 – 130 min (72, 73, 75, 76, 
78). Also, the use of gas chromatography for thermally degradable chemicals such as 
steroid hormones is questionable.  
1.2.3. IMMUNOASSAY 
Immunoassays are widely used in clinical laboratories for steroid analysis in the 
serum or plasma.  Immunoassay measures the concentratio  of the analyte using the unique 
molecular recognition properties of an antibody (94). Immunoassays are widely applicable, 
specific, and sensitive (LOD < 0.3 – 64 ng/L) (80-88, 96, 97). The instrumental equipment 
is relatively cheap and accessible. However, the analysis can be affected by the cross-
reactivity of antibodies with steroid metabolites from the sample matrix as many of the 
immunoassays are preformed directly on a non-purified plasma or serum samples to 
decrease the analysis time or on a sample pretreated with the extraction or chromatographic 
purification prior to incubation with an antibody (95). Immunoassay cannot be used for 
steroid profiling, since the method is typically used for analysis of one steroid at a time. To 
analyze several steroids in a single sample one would need to partition the sample and 
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incubate each portion of the sample with a specific steroid antibody. Typically 
immunoassay requires 10-200 µL of a reconstituted plasma sample to be introduced in ach 
well of a 96-well mirotiter plate for incubation (81, 85-87, 95, 97). Since the volume of 
plasma sample available from a single fish is typically from 10 µl to < 1000 µl, the entire 
sample of fish plasma is often used to determine one steroid only. Given the likelihood of 
variations of steroid concentrations between fish plasma samples, profiling using multiple 
fish plasma samples is error prone, not to mention the increased analysis time since  the 
incubation time in immunoassay ranges from 45 – 90 min up to several hours (80-82, 84-
88, 96). Finally, the immunoassay analysis should be confirmed using GC-MS or LC-MS.  
For example, isotope dilution GC-MS does not suffer from cross-reactivity and does not 
depend on the presence of interferences in plasma sa ples as a result it has been used as a 
“gold” reference standard method for validating immunoassays (89). Figures of merit for 
steroid analysis reported in the literature are summarized in Table 1.1.    
1.2.4. CAPILLARY ELECTROPHORESIS  
Capillary electrophoresis (CE) provides rapid and unsophisticated method 
development, versatility, high efficiency and resoluti n, various modes to vary selectivity, 
simple separation mechanism and extremely small sample volumes required (98-101). CE 
separations are faster comparing to other methods discussed above. For example, previous 
works reported steroid analysis separation times les than 14 min using conventional 
capillaries (102-112) and less than 7 min with microfluidic devices (102). In addition, in 
CE the same instrument can be used for the separation nd analysis of a wide range of 
analytes such as large biomolecules (proteins and nucleic acids), metal and organic ions, 
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enantiomers and neutral molecules. These advantages of CE can help overcome the 
shortcomings of LC-MS, GC-MS, and immunoassay for steroid analysis discussed earlier.  
CONCLUSIONS 
The goal of the research presented within the framework of this dissertation is the 
development of an analytical technique which would a low for the high-throughput 
determination of the low concentrations of endogenous steroids in fish blood or plasma in 
order to be able to control the cause and effects of the endocrine disruption in aquatic 
fauna. As discussed above, many analytical methods ave been developed for the analysis 
of steroids in environmental and biological samples. Despite the advantages of the low 
detection limits these methods are time consuming and are difficult to apply to volume-
limited plasma samples. These technical difficulties suggested a need for a new approach to 
hormone analysis compatible with stringent demands of high throughput screening in real 
life applications dealing with small sample volumes and complicated matrix composition.  
Chapter 2 discusses the fundamentals of capillary electrophoresis, which was 
chosen as the baseline approach for analysis of steroid hormones. Development of the 
separation protocol using micellar electrokinetic chromatography under acidic conditions to 
rapidly separate steroids is outlined in this chapter as well. The developed method is 





Table 1.1. Figures of merit for steroid analysis by literature m thods. Literature search was limited to the publications published by 2008 and reported analysis of 
at least two (or one for immunoassay) of the following steroids: progesterone (P), testosterone (T), estrone (E1), estradiol (E2), and estriol (E3). Sample was 
either blood serum or blood plasma. 
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The long term goal of the research presented in this c apter was to develop a CE 
method for profiling steroids in blood plasma of fish which can assist in monitoring 
endocrine disruption. In order to fully understand the principle of the analytical approach 
used in this study a brief review of the capillary electrophoresis, micellar electrokinetic 
chromatography (MEKC) and cyclodextrin-modified MEKC based on introduction to the 
high performance capillary electrophoresis by Heiger (1) is presented below.   
2.1.1. THEORY OF CAPILLARY ELECTROPHORESIS 
Capillary zone electrophoresis (CZE) of ionic species using narrow inner diameter 
fused silica capillaries (< 100 µm), high voltage up to 30 kV and on-line UV-visible 
absorbance detection was first demonstrated by Jorgenson and Lukacs in 1981 (2), who 
also investigated the relationships between the operational parameters and separation 
quality of CE (3, 4). The separation of analytes in CE is affected by two transport 
processes: electrophoresis and electroosmosis. The net result of both is the separation of 
charged and neutral analytes. Separation of charged analytes is based on their respective 
charge-to-size ratios. Electrophoresis is the movement of a charged solute through a 
conductive solution toward or away from an electrode (anode or cathode) by the electric 
field. The movement of the solute depends on the mobility of the solute and the magnitude 
of the applied electric field and is called the electrophoretic velocity (ve): 
Ev ee µ=  (2.1) 
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where values ve, µe, and E are ion velocity, electrophoretic mobility, and applied electric 
field, respectively. The electric field is a function of applied voltage and capillary length (in 






=  (2.2) 
where q, r, and η are ion charge and radius, and viscosity of the solution, respectively. 
Cationic solutes with the largest charge-to-size ratio have therefore the highest net mobility 
and elute faster toward the cathode. For anions the trend is opposite while for neutral 
(uncharged) solutes electrophoretic mobility is zero. Figure 2.1 shows CE separation at 
normal polarity where the cathode and the anode are at the outlet and at the inlet of the 
capillary respectively. The opposite arrangement of he cathode and the anode will be 
referred to as reversed polarity in this dissertation.  
 
Figure 2.1. Schematic representation of separated analyte bands in CE and EOF.  
Electroosmotic flow (EOF) is a distinctive element of CE. EOF is the bulk 
movement of the solvent being dragged by the positively-charged ions migrating toward 
the cathode. As mentioned above, CE is usually performed in capillaries made from fused 
silica. Surface charges on the interior of the capillary induce the formation of a double layer 
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upon application of the electric field. In a fused silica capillary, the surface silanol (Si-OH) 
groups are ionized to negatively charged silanoate (Si-O¯ ) groups at pH above three. These 
negatively charged silanoate groups attract positively charged cations from the buffer 
solution, which form an inner layer of cations (Stern layer) at the capillary wall. The 
density of these cations is not sufficient to neutralize all the negative charges, so a second, 
outer layer of cations (Gouy-Chapman layer) forms. The electric potential at the sheer 
plane of the double layer is called the zeta (ζ) potential. While the inner layer is tightly held 
by the Si-O¯  groups, the outer layer of cations is not tightly held because of its larger 
distance from the silanoate groups. Under the influe ce of an electric field, the outer layer 
of cations is pulled toward the negatively charged cathode. Since these cations are solvated, 
they drag the bulk buffer solution with them, thus causing EOF, as represented in Figure 
2.1. The existence of the EOF means that under normal polarity neutral and charged 
molecules, even negatively charged ones, will be swept along towards the cathode.  
The magnitude of EOF is highly dependent on the pH of the running buffer because 
the ζ− potential is largely controlled by the ionization f the acidic silanols on the capillary 
wall. At pH ≤ 3, the ionization is small and the EOF flow rate is therefore not significant. 
At pH ≥ 9 the silanols are fully ionized and EOF flow rate is high. For example, in 20 mM 
borate buffer at pH 9.0 in a 50 µm inner diameter capillary the velocity of EOF is 
approximately 4 nL/s. The magnitude of EOF also decreases with increased concentration 
of the running buffer. Increasing ionic strength causes double-layer compression, which 
results in reduction of the level of EOF. Additionally higher ionic strength will increase 
the current across the capillary and increase the likelihood of Joule heating and band 
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broadening (5, 6). EOF can be suppressed by chemically coating the inn r surface of 
capillaries (7-9) or by using acidic running buffer (10). 
EOF is generated throughout the entire length of the capillary and is characterized 
by a flow profile that is plug-like in nature. Consequently, solutes are swept along at the 
same rate regardless of their radial position in the capillary minimizing sample dispersion. 
This is an advantage compared to the laminar flow encountered in pumped systems such as 
in HPLC. In laminar flow, the solution is pushed from one end of the column. The solution 
at the column walls moves slower than the solution in the middle of the column due to the 
shear effect resulting in different solute speeds across the cross-section of the column. 
Therefore, the laminar flow tends to broaden the peaks as they travel along the column.  
The apparent mobility µa of a solute is the sum of its electrophoretic mobility and the 
electroosmotic mobility:  
µa = µe + µEOF  (2.3) 
Under normal polarity the apparent mobility of cationic species is therefore 
generally greater than EOF (Fig. 2.1). Neutral species do not have charges and therefore 
migrate as a single peak at the same velocity as EOF. Apparent mobility of anionic species 
is smaller than EOF since the anions have electrophoretic attraction toward the anode while 
EOF is driven by the cathode attraction. If EOF is strong enough, all species will migrate 




CE offers high efficiency, selectivity, and low cost peration. CE instrumentation is 
schematically shown in Figure 2.2-A. The key component is the separation capillary filled 
with running buffer. The length and inner diameter of a separation capillary typically range 
from 30 to 100 cm and 10 to 100 µm respectively. Both ends of the capillary are 
submerged into buffer vials also containing platinum electrodes. The sample is introduced 
at the inlet site by applying a high voltage potential (electrokinetic injection) or by pressure 
(hydrodynamic injection). Migration through the capill ry is driven by the applied field, 
and analytes are detected on-capillary as they pass a detection window at the capillary 
outlet. The high voltage power supply is capable of supplying up to 30 kV voltage across 
the capillary to assist sample injection and separation. Most commercial instruments use 
UV-visible absorbance detection. This is accomplished in-capillary by burning off a 
portion of the polyimide coating from the fused silica to form a detection window. The 
output of the detector is a plot of detector respone versus time and is called an 
electropherogram (Fig. 2.2-B).  
  
A B 
Figure 2.2. Schematic diagram of a CE instrument (A), and a representative CE electropherogram (B). 
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In CE the range of separated molecules is limited to those carrying a charge. The 
co-elution of neutral analytes in the CZE is one of the major limitations of electrophoresis. 
Steroid molecules are neutral and therefore require a pseudo-stationary phase to assist 
separation by means of secondary equilibria. Micellar e ectrokinetic chromatography is an 
extension of capillary electrophoresis which is used to separate neutral molecules (11-17). 
2.1.3. MICELLAR ELECTROKINETIC CHROMATOGRAPHY (MEKC) 
Micellar electrokinetic chromatography (MEKC) for the separation of neutral 
compounds by adding surfactants such as sodium dodecyl sulfate (SDS) to the running 
buffer was first introduced in 1984 by Terabe and co-workers (11).  Micellar electrokinetic 
chromatography combines the phenomenon of EOF with a form of partition 
chromatography to expand the range of separated molecules including neutral molecules. 
EOF drags all the neutral molecules through the capillary with essentially the same rate. 
Partition chromatography in its simplest form consists of a stationary phase and a mobile 
phase where the separation of molecules is based on different affinities of the analytes for 
the two phases. The separation of neutral analytes can be achieved by introducing charged 
additives, such as surfactants, soluble polymers, crown ethers, cyclodextrins, antibodies, 
and proteins into the running buffer solution. The most popular additive is a surfactant.  
The surfactant molecules are amphiphilic with both hydrophobic (e.g., alkyl 
moiety) and hydrophilic (polar or charged) groups, and they behave as solvated monomers 
at very low concentrations. When the concentration is i creased beyond a minimum level, 
termed the critical micelle concentration (CMC), these monomers spontaneously start to 
form micelles. A micelle is an ordered aggregate of sur actant monomers enclosing their 
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hydrophobic tails and exposing polar head groups toward the water or other polar solvents 
(Fig. 2.3) (18).  
 
 
Figure 2.3.  Micelle formation (top). Sodium dodecyl sulfate (SDS) monomer (bottom). 
 
The micelles in MEKC are the equivalent of the stationary phase in HPLC and 
often called pseudostationary phase. Because micelles are not stationary, they are subject to 
both EOF and electrophoresis. Separation in MEKC is thu  based on the different ability of 
the analyte molecules to partition between the solution and the inside of the micelles. In the 
presence of EOF, all the analyte molecules and the mic lles will pass through the detector 
window because the negatively charged micelles are att acted to the anode, but the greater 
magnitude of the EOF sweeps them toward the detector at he cathode end of the capillary. 
In reality, solutes are distributed in MEKC between the pseudostationary and aqueous 





P =   (2.4) 
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where, CPS and Cs are the molar concentrations of a solute in the pseudostationary and 
aqueous phase respectively. Both, CMC and partition c efficient are temperature 
dependent. An increase in temperature causes an increase in CMC, hence a decrease in 
micellar concentration which consequently reduces th  retention factor. On the other hand, 
higher temperatures lower the partition coefficient a d also reduce the retention factor (19). 
It is well known that temperature increase reduces th  viscosity of the running buffer which 
ultimately increases electrophoretic and EOF velocities and reduces the migration time. 
Therefore in order to maintain a reproducible MEKC separation temperature control is 
critical (20).  
In all separation techniques, the primary goal is to achieve good resolution, Rs. In 





∆= tRs  (2.5) 
where ∆t is the difference in migration time of two analytes, and ω is the peak baseline 
width in time units. The resolution in MEKC can be improved by optimizing efficiency, 
selectivity, and retention factor. The latter is the easiest to control since in general, there is 
a linear correlation between an increasing concentration of the surfactant. However, a 
potential problem when using too concentrated surfactants is an increase of Joule heating 
due to an increase in the effective resistance, thus t e dissipated power (V⋅I = I2⋅R) of the 
running buffer (21). Even with the narrowest capillaries, an efficient cooling is necessary to 
eliminate the excess heat generated by extremely high electric field.  
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Another way of improving the resolution is to extend the elution window. In the 
separation of neutral analytes, all analytes elute between tEOF and tmicelle. Hydrophobic 
analytes totally retained in micelles elute with them at tmicelle. On the other hand, very 
hydrophilic analytes do not interact at all with micelles and elute with EOF. Even though 
the elution window is often fairly small, the peak capacity can be very high because of the 
high efficiency. It is also easy to manipulate the selectivity by changing the physical nature 
of the micelle such as size, charge, and geometry and by using different surfactants. The 
use of surfactants may have dramatic affect on the EOF by interacting with the capillary 
wall. When EOF is suppressed only charged pseudostationary phase migrates through the 
aqueous phase.   
Unfortunately, CE separations of native steroids cannot be accomplished with the 
use of only micellar hydrophobic pseudostationary phase because lipophilic steroidal 
compounds readily partition inside of SDS micelles in aqueous solutions and often co-
migrate. The separation of steroids by MEKC requires the secondary equilibrium by 
means of the introduction of another additive to the running buffer. One such additive is 
cyclodextrin which is used to control the high affinity of steroids to the micelles and thus 
the separation resolution and efficiency (22-24). The background on cyclodextrin 
chemistry is briefly discussed below. 
2.1.4. CHEMICAL AND PHYSICAL PROPERTIES OF CYCLODEXTRINS 
Cyclodextrins are well-known in host-guest chemistry. Cyclodextrin (CD) was first 
mentioned in 1891 by Villiers; however, Schardinger ave the first detailed description of 
the preparation and isolation of this group of macrocyclic molecules and helped develop 
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the fundamentals of CD chemistry. Later in the 1930s, Pringsheim significantly advanced 
the progress of CD research when he discovered that org nic compounds have a tendency 
to form complexes with crystalline CDs (25). The compounds are industrially synthesized 
from the degradation of starch mediated by the simple enzymatic conversion. CDs are non-
toxic and can be widely used in food, medication, and cosmetics (26). 
 
Figure 2.4. Chemical structure of a β−cyclodextrin molecule. 
CD is a cyclic oligomer of α-D-glucose. CD normally used in the analytical 
separations are α-cyclodextrin (six glucose units); β-cyclodextrin (seven units), and γ-
cyclodextrin (seven units). The CD molecule resembls a doughnut and is typically 
represented as a shallow truncated cone (Fig. 2.4). For a molecule with m glucose units, 
one cavity opening is contoured with m primary hydroxyl groups and has a reduced 
diameter compared to the other cavity opening contoured with 2m secondary hydroxyl 
groups. The interior of the cavity is decorated with a row of CH groups (C-3 carbons) then 
a row of glycosidic oxygens, and then a row of CH groups (C-5 carbons).  
The hollow structure makes the cyclodextrin attractive subjects for chemical studies 
and applications. Whereas the interior of the cavity is non-polar, the exterior of the 
cyclodextrin is covered with hydroxyl groups making t soluble in water (27).  At 25 ºC, the 
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least soluble is β-CD (1.85 g/100 mL), and most soluble is γ-CD (23.2 g/100 mL). These 
compounds are therefore studied as “hosts” for “guest” molecules capable of entering the 
cavity partially or completely and forming non-covalent host-guest inclusion complexes. 
Since cyclodextrins are neutral molecules, they move along with the EOF. In addition, they 
are inert and stable at a wide range of pH values, and have low UV absorptivity at short 
wavelengths. These properties make them very useful additives in chromatographic 
applications. Table 2.1 summarizes dimensions and physical properties of cyclodextrin 
molecules (28).  
Table 2.1. Physical and chemical properties of CDs.  
CD  




Solubility in water, 
g/100 mL  
A, Å  B, Å  C, Å  
α  6  972  14.5  14.6  4.7 – 5.3  7.9  
β  7  1135  1.85  15.4  6.0 – 6.5  7.9  
γ  8  1297  23.2  17.5  7.5 – 8.3  7.9  
 
To overcome the limited selectivity of MEKC the addition of cyclodextrins into the 
micellar phase is used to prevent the elution of highly hydrophobic analytes with micelles. 
This technique is referred to as CD modified MEKC. 
2.1.5. CYCLODEXTRIN (CD) MODIFIED-MEKC 
Due to the presence of a relatively hydrophobic cavity in CDs, they act as another 
pseudostationary phase and significantly contribute to the selectivity of the separation 
system. When a CD is added into the micellar system, he CDs and micelles compete to 
form inclusion complexes with the analyte. Because native CDs are neutral, the analytes 
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having greater affinity to neutral CD migrate at the velocity of the EOF. The success of 
desired selectivity depends on the binding constant of he analyte with CD and the 
concentration of the CD, as the change in the concentration will shift the equilibrium 
toward to or away from the formation of the analyte-CD inclusion complex. Addition of a 
very high concentration of CD might, however, disturb the micelle formation (29).  
The literature publications reported the MEKC analysis of sex steroid hormones are 
summarized in Chapter 1.  Most works so far have, however, focused mainly on the 
optimization of the separation parameters and do not report required figures of merit, such 
as LODs, the reproducibility of the method nor its validation using biological samples. The 
analysis of steroids by cyclodextrin modified MEKC is the focus of this dissertation and 
will be discussed in details below in this chapter. The method is optimized to enable 
selective and rapid analysis of steroids. Two particular aspects are addressed: 1) how the 
affinity of targeted steroids either to the micelles or to CDs affects the migration order of 
the steroids in basic and acidic separation media, and 2) possible ways of manipulation and 




2.2.1. CHEMICALS AND MATERIALS 
Sodium dodecyl sulfate (SDS), 3-[cyclohexylamino]-1-propanesulfonic acid 
(CAPS), 2-[cyclo-hexylamino]-ethanesulfonic acid (CHES), n-decanophenone, 11-
ketotestosterone, and testosterone were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Hydroxypropyl-β-cyclodextrin (HPCD) was purchased from VWR (West Chester, 
PA, USA). Steroids, androstenedione, 17β-estradiol, estrone, 17-hydroxyprogesterone, and 
progesterone were purchased from Steraloids, Inc (Newport, RI, USA).  17α-ethynyl 
estradiol was purchased from Cayman Chemical (Ann Arbor, MI, USA). Sodium 
phosphate monobasic salt was purchased from Fisher Sci ntific (Fair Lawn, NJ, USA).  
Methanol was purchased from EMD Chemicals (San Diego, CA, USA).  Deionized water 
was purified using ELGA Purelab Ultra (Lowell, MA, USA).   
Buffered solutions were prepared by weighing solid reagents, dissolving them in 
deionized water, and adjusting pH of the solution with aqueous solutions of 1N 
hydrochloric acid or 1N sodium hydroxide, as appropriate. Standard stock solutions of each 
sex steroid hormone were prepared by weighing out the solid steroid reagent and dissolving 
it in methanol.  Before use, all the prepared steroid stock solutions were stored in a freezer 
at –20 °C and in the dark to avoid possible degradation. Stock samples were diluted to a 
desired concentration each day prior to use with the proper buffer. The CE background 
electrolyte and the samples to be analyzed were prepared fresh every day prior to use. 
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The presence of air bubbles should be eliminated as they can be injected into a 
capillary where they can cause large resistance during the electrophoresis leading to 
disruption or large fluctuations of the separation current during electrophoresis (from 
Ohm’s law: V = I ⋅ R, where V is the potential applied across the separation capillary in 
volts, R is the resistance in ohms, and I is the current in amperes). Micro-sized air bubbles 
can also be generated by Joule heating during electrophoresis, blocking the flow pathway 
and causing the current fail. In order to remove th dissolved air bubbles trapped in the 
solution the vials containing freshly made running buffers and samples were degassed 
using vacuum for 1 min for 2 mL vial or 15 sec for 250 µL vial. Ultrasonication was also 
used for this purpose when necessary. All buffer solutions were filtered using 0.45 µm 
porous filters before use to remove foreign particles which can clog the capillary or be 
injected and interfere with the separation analysis producing extra peaks in the 
electropherogram. 
2.2.2. INSTRUMENTATION 
CE measurements were carried out using a Beckman Coulter P/ACE MDQ 
capillary electrophoresis instrument (Beckman coulter, Fullerton, CA, USA) (Fig. 2.5). The 
instrument was equipped with a photodiode array UV-visible absorbance detection system 
(PDA) which provided simultaneous determination of steroids at multiple wavelengths in a 
single analysis or with photomultiplier tube (PMT) which allowed the detection of steroids 
at a specific wavelength.  
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Instrument Inside Capillary cartridge 
Figure 2.5. Photographs of the Beckman® automated capillary electrophoresis machine used in the work. The 
light source is a UV-visible absorbance, with a PMT or PDA detector. 
The electropherograms were collected at the wavelengths of UV-light where the 
analytes showed strong light absorption (200 nm for est ogens, 254 nm for androgens and 
progesterone, or 225 nm for all targeted steroids). All separations were performed using 26 
µm inner diameter (id), 360 µm outer diameter (od), 30 cm long fused silica separation 
capillary (Polymicro Technologies, LLC, Phoenix, AZ, USA) with the detection window 
positioned 10.2 (short end separation) or 19.8 cm (long end separation) from the cathodic 
or anodic reservoir located at the sample inlet. The temperature of the capillary cartridge 
and sample storage trays inside the instrument was maintained at 25 ± 1 ºC because the 
distribution coefficients are temperature sensitive.  
2.2.3. MEKC AT PH 10 PROCEDURE  
For this experiment, the running buffer containing 30 mM HPCD and 50 mM SDS 
dissolved in 50 mM CHES buffered at pH 10 was used. The steroid sample was prepared 
by adding aliquots of standard methanol stock solutions of six sex steroid hormones, 
estrone, 17β-estradiol, estriol, testosterone, α,β-dihydroxyprogesterone and progesterone, 
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to the running buffer. The concentration of each steroid in the final dilution was 200 µM. In 
order to avoid steroid precipitation the organic content was maintained at 20 % of methanol 
in the sample. However, the addition of small amounts of methanol increases the CMC of 
SDS. In fact, when the methanol content of the solution is 40% v/v or more the inverted 
micelles begin to form. In an inverted micelle, the polar head-groups of the surfactant 
monomers are centered in the interior while the lipophilic tails stand out into the nonpolar 
solvent (30). n-Decanophenone was used as the hydrophobic micelle marker. The sample 
was hydrodynamically injected into a silica capillary (effective length to the detection 
window Lw = 19.8 cm) at 3.4 kPa (0.5 psi) for 4.0 sec. Separation was performed with a 16 
kV potential drop across the capillary and normal polarity (cathode at the outlet), while 
being monitored at a detection wavelength of 225 nm where all steroids absorb light 
equally well and can be detected in a single run.  
2.2.4. MEKC AT PH 2 PROCEDURE 
The running buffer is comprised of 18 mM HPCD and 30 mM SDS dissolved in 10 
mM phosphate buffered at pH 2.0. Standard solutions of steroids progesterone, 17α,20β-
dihydroxyprogesterone, testosterone, androstenedion, estrone, 17β-estradiol, and estriol 
were prepared in the running buffer at the concentrations of 100 µM progesterone and 
17α,20β-dihydroxyprogesterone, 150 µM testosterone and 17β-estradiol, 200 µM 
androstenedione, and 250 µM estrone with the addition of 20 % methanol. Steroid sample 
was injected into a bare fused silica capillary (effective Lw = 10.2 cm) at 3.4 kPa (0.5 psi) 
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for 3.0 sec. CE was performed at 16 kV and reversed polarity (anode at the outlet), and the 
detection wavelength of 225 nm. 
2.3. RESULTS AND DISCUSSION 
2.3.1. STEROIDS TARGETED FOR ANALYSIS 
The goal of the research presented in this dissertation chapter was to develop a 
rapid method to profile relative change in the steroid composition to better define 
physiological dysfunction following exposure to endocrine-disrupting chemicals. A 
simplified steroid metabolism pathway was used as a basis for the steroids targeted for 
analysis. The initial separation targets were progesterone, hydroxyprogesterone, 11-
ketotestosterone, estrone, estradiol, and ethynyl estradiol. These analytes were selected 
because of their role in enabling or disrupting the c mical messaging in blood plasma 
samples. The presence of these steroidal compounds would therefore offer insight into 
the pathways involved in environmentally triggered ndocrine disruption in fish. The 
molecular properties of the targeted steroids are summarized in Table 2.2.  
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Table 2.2. Molecular properties of targeted steroids a 





4.5 2 2 296.40 
17β-estradiol 50-28-2 (17β)-estra-1,3,5(10)-triene-3,17-diol  4.1 2 2 272.38 
progesterone  57-83-0 pregn-4-ene-3,20-dione 4.0 2 0 314.46 
Estrone 53-16-7 3-hydroxy-estra-1,3,5(10)-trien-17-one 3.7 2 1 270.37 
Testosterone 58-22-0  (17β)-17-hydroxy-androst-4-en-3-one 3.5 2 1 288.42 
Estriol 50-27-1 (16α,17β)- estra-1,3,5(10)-triene-3,16,17-triol 2.9 3 3 288.38 
αα-dihydroxy 
Progesterone 
652-69-7 (20S)-17,20-dihydroxy-pregn-4-en-3-one  2.9 3 2 332.48 
αβ-dihydroxy 
Progesterone 
1662-06-2 (20R)-17,20-dihydroxy-pregn-4-en-3-one 2.9 3 2 332.48 
17-hydroxy-
progesterone 
68-96-2 17-hydroxy-pregn-4-ene-3,20-dione 2.9 3 1 330.46 
Androstenedione 63-05-8 androst-4-ene-3,17-dione 2.9 2 0 286.41 
11-keto 
Testosterone 
564-35-2 (17β)-17-hydroxy-androst-4-ene-3,11-dione 1.7 3 1 302.41 
Log P – logarithm of partition coefficient; HA – number of proton acceptors; HD – number of proton donors.  
aValues reported by Scifinder, version 2006; Chemical Abstract Services: Columbus, OH, 2006; CAS #, MW, log D, 
HA and HD calculated using Advanced Chemistry Development (ACD/Labs) Software V8.14 for Solaris (© 1994-




2.3.2. MEKC SEPARATION OF STEROIDS IN AN ALKALINE MEDIUM 
In the early phase of the method development, the separation of sex steroid 
hormones was performed in the basic medium by MEKC. The alkaline buffer consisted of 
CHES buffered at pH 10. SDS was used as the micelle forming agent due to SDS possesses 
high aqueous solubility, low critical micelle concetration (8 mM), low UV molar 
absorptivity, availability and small cost. HPCD was used as a cyclodextrin additive. 
Theoretically these separations are possible using any neutral β−CD; however, HPCD has 
higher aqueous solubility in contrast to an unsubstituted CD (31), and it was therefore used 
in this work. The molecular substitution of the HPCD was not controlled.  
2.3.2.1. Separation Mechanism 
EOF has a high velocity at pH 10. Neutral cyclodextrins migrate along with the 
EOF while SDS micelles migrate slower due to their anodic electrophoretic mobility. 
Neutral steroids are separated based on the differenc  in the distribution coefficients 
between a polar aqueous buffer and the non-polar micelle or unoccupied cyclodextrin 
cavities (32). Figure 2.6 illustrates a schematic diagram of the separation process as well as 
the acquired electropherogram for steroids separated via pH 10 method. All targeted 
steroids were separated in less than 3.5 minutes, substantially faster than standard 
immunoassay analysis. The elution order of the steroids in the basic medium corresponds 
to increasing affinity of the analytes to SDS (Fig. 2.6, right). Estriol, 17β-estradiol, and 
estrone migrate first due to their preferential interaction with HPCDs while testosterone, 
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α,β-dihydroxyprogesterone, and progesterone migrate las  due to their stronger partitioning 
into SDS micelles.  
 
 
Figure 2.6. MEKC of steroids in alkaline medium. Schematic diagram of the separation process is on the right 
and the resulted electropherogram is on the left. E3 – estriol, E2 – 17β-estradiol, E1 – estrone, T – 
testosterone, DHP – 17α,20β-dihydroxyprogesterone, and P – progesterone, at 200 µM each. Injection 
conditions: 0.5 psi, 4.0 sec, Lw = 19.8 cm. Separation at 16 kV, normal polarity. Detection at λ=225 nm. 
Separation of estriol, 17β-estradiol, and estrone is due to the difference in their 
chemical structures, namely the presence of the hydrophilic hydroxyl and ketone groups 
attached to the ring D. According to the literature, hydrophilic hydroxyl groups remain 
exposed to the solvent even after forming a complex with cyclodextrin (28, 33). The 
aromatic hydroxyl group is an exception to the rulebecause it can penetrate deeply into the 
cyclodextrin cavity where it forms hydrogen-bonds to one of hydroxyl groups in 
cyclodextrin molecule (34). The host-guest stoichiometry is reported to be 1:1 (35, 36). The 
pH 10 separation data shows that estriol has the highest association with cyclodextrin 
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followed by 17β-estraiol and estrone at the experimental conditions.   
2.3.2.2. Figures of Merit 
Calibration curves for the separation of sex steroid hormones using MEKC were 
determined from nine calibration curves measured 3 per day for 3 days. The linear range 
and correlation coefficients obtained for the pH 10 separation system are summarized in 
Table 2.3 below.  The curves were measured separately for each analyte. Detection was 
performed by UV-visible absorbance at detection wavelength of 200 nm for estrone, 17β-
esradiol, and estriol, or 254 nm for androstenedione, dihydroxyprogesterone, and 
progesterone.  
Table 2.3. Linear range of steroid detection via pH 10 MEKC separation. 
 E1 E2 E3 AD α,β−DHP P 
Linear range,  µM 
(×102) 
 
0.50-4.0 0.50-16 0.50-16 0.50-16 0.30-1.0 0.50-16 
R2 0.993 0.999 0.999 0.991 1.00 1.00 
 
2.3.3. MEKC SEPARATION OF STEROIDS IN AN ACIDIC MEDIUM 
If the pH of the running buffer is less than three, the velocity of the EOF 
approaches zero and thus does not assist the separation of the analytes. In this experiment, 
the separation of steroids under acidic conditions wa performed at reversed polarity (anode 
at the outlet) because under suppressed EOF neither neutral cyclodextrins, which have the 
velocity of EOF, nor SDS micelles attracted to the anode would reach the detection 
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window if the normal polarity (cathode is at the outlet) was used. Phosphate buffered at pH 
2.0 containing SDS and CD was used as a background electrolyte. At the reversed polarity 
experimental conditions the SDS micelles carrying steroid molecules migrate faster than 
the EOF (Fig. 2.7, left). As a result, the steroids with higher affinity to the micelles will 
migrate earlier followed by the steroids with higher affinity to the cyclodextrins. 
 
 
Figure 2.7. Electropherograms measured for steroids under acidic separation conditions. P – progesterone 
(100 µM), DHP – 17α, 20β-dihydroxyprogesterone (100 µM), T – testosterone (150 µM), AD – 
androstenedione (200 µM), E1 – estrone (250 µM), E2 – 17β-estradiol (150 µM). Injection conditions: 0.5 psi, 
3.0 sec. Lw = 10.2 cm.  Separation at 16 kV, reversed polarity. Detection at: λ=225 nm. 
The resulting electropherogram is shown in Figure 2.7 (right). All the steroids, 
except for estriol, were separated in less than 5 minutes. At pH 2.0, estriol (not shown) 
migrates very slowly because of its strong affinity to the cyclodextrin. As a result, estriol 
peak is very broad, yielding small signal-to-noise ratio and unsuitable for chromatographic 
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quantitation. However, by manipulating the SDS to HPCD ratio or the separation voltage it 
is possible to force estriol to migrate faster as a sh rp peak at the expense of lowering the 
resolution for early migrating steroids. The effect of the capillary length to the detection 
window and SDS to HPCD ratio on the separation time, resolution and selectivity is 
discussed below.  
2.3.4. EVALUATION OF MEKC OF STEROIDS IN STRONGLY ACIDIC MEDIUM (PH 2)  
Separation in highly acidic media can be complicated since the analytes move 
through the capillary much slower under suppressed EOF. However, the separation time 
can be decreased by increasing the separation voltage. It can also be decreased by 
decreasing the length of the capillary, albeit at the expense of the resolution. Additionally, 
an increased capillary length leads to a decrease of the electric field strength at constant 
voltage (E = V/L, V – applied voltage, L – capillary length) and higher voltages have to be 
used for the separation.  In CE, it is common to start a method development using a shorter 
capillary (typically 20 – 50 cm to the detection window) and then change the length of the 
capillary until the best resolution for all the analytes is achieved. The length of the 
separation capillary used for both types of CE analysis was 30 cm. In pH 10 method the 
detection window was positioned 19.8 cm from the inj ction point while the other end of 
the capillary was positioned 10.2 cm from the detection window. This method is referred to 
as the long end separation. In pH 2 method the effective length of the capillary was 10.2 cm 




Figure 2.8 shows the separation of steroids injected a  short and long ends of the 
separation capillary. Even though the resolution improves, the detection signal decreases 
for slower migrating analytes such as ethynyl estradiol due to band broadening effects 
caused by longitudinal diffusion. Longitudinal diffusion is the diffusion of the solute 
molecules from the center of the analyte zone to the more dilute regions in front of and 
behind the zone. On the other hand it is evident that a short end separation under acidic 
conditions results in at least 60 % faster separation comparing to the long end separation 
and the separation efficiency (the narrow shape of the peak) for ethynyl estradiol improved 
dramatically which was predicted by the theory; however, the resolution suffered in the 
short end separation leading to the overlapping peaks for testosterone and androstenedione 
(Fig. 2.8-A). 
 
Figure 2.8. Acidic MEKC of steroids injected hydrodynamically (0.5 psi, 4 sec) at short end (A) and long end 
(B). 350 µM progesterone (1); 250 µM hydroxyprogesterone (2); 500 µM testosterone (3); 400 µM 
androstenedione (4); 300 µM ethynyl estradiol (5).  BGE: 40 mM SDS, 20 mM HPCD, 20 % methanol in 10 
mM phosphate buffered at pH 3.1. Separation: 16 kV and normal polarity. 
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The poorer resolution of testosterone and androstenedio e peaks in the short-end 
analysis can be improved by changing the SDS/HPCD ratio of the running buffer as 
illustrated in Figure 2.9. As discussed earlier, the steroids with a higher affinity to SDS 
micelles migrate first under acidic conditions and reversed polarity. The migration order of 
steroids under acidic conditions (Fig.2.8-B) demonstrates that testosterone has higher 
affinity to SDS comparing to androstenedione which preferentially forms inclusion 
complexes with CD. If the ratio of SDS to HPCD is hgh the equilibrium will be shifted 
toward the inclusion of the steroids inside of SDS micelle cores and therefore steroids will 
spend more time travelling with the micelles thus migrating faster and producing worse 
resolution (Fig. 2.9-A). By increasing the amount of HPCD in the separation buffer the 
equilibrium is shifted toward the formation of the inclusion complexes of steroids with 
cyclodextrin cavities. Therefore, if the amount of HPCD in running buffer is increased 
androstenedione can be separated from testosterone. The representative electropherograms 
shown in Figure 2.9 were obtained using three running buffers of different ratios of 




Figure 2.9. Short end separation of steroids in acidic MEKC. SDS/ HPCD is 2.2 (A), 2.0 (B), 1.7 (C). Sample 
injected hydrodynamically at 0.5 psi, 4 sec. 350 µM progesterone (1); 250 µM hydroxyprogesterone (2); 500 
µM testosterone (3); 400 µM androstenedione (4); 300 µM ethynyl estradiol (5). BGE is SDS/HPCD, 20% 
methanol in 10 mM phosphate buffered at pH 3.1. Separation at 16 kV and normal polarity.  
The electropherogram in Figure 2.9-C demonstrates baseline resolution for all 
peaks obtained using SDS/HPCD = 1.7 although ethynyl estradiol peak is too broad if 
SDS/HPCD ≤ 1.7. The analysis time however is 40 % faster for the short end comparing to 
the long end separation and is beneficial for the fast screening of multiple steroid samples.    
CONCLUSIONS  
The separation of selected steroid hormones by conventional MEKC has been 
conducted under both basic and acidic conditions. The study has shown that the migration 
order of steroids depends on their affinity to the hydrophobic cavities of SDS micelle or 
cyclodextrin molecule and can be manipulated by changing the pH of the running buffer 






the steroid peaks in the electropherogram depends o the ratio of SDS to cyclodextrin in 
the running buffer and therefore can be controlled. The electropherograms measured at 
basic conditions demonstrated the baseline separation of steroids in less than 3.5 min. The 
separation in acidic medium under suppressed EOF was achieved in less that 5 min. The 
latter was obtained using reversed polarity and a short end separation with the effective 
length of the capillary being 10.2 cm from the injection point to the detection window. 
Although the acidic method yields baseline resolved p aks and fast separation of steroids, 
the limits of detection for steroid analysis must still be compatible with the low levels of 
endogenous steroids in plasma. The development of a preconcentration technique for 
improving the steroid detection limits by MEKC-UV-visible absorbance detection is the 
subject of the next chapter.  
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C H A P T E R  3 




While the MEKC separation described earlier is fastand consumes low sample 
and reagent volumes, it has poor concentration limits of detection if measured by UV–
visible absorption due to limited sample loading capacity and small path length for light 
absorbance. In CE, the inner diameter of the separation capillary has to be smaller than 100 
µm to minimize the solute dispersion caused by Joule heating and to obtain the high 
separation efficiency (1). A detection window in a silica capillary is prepared by burning 
off polyimide coating from a segment of the capillary. Due to a small diameter of the 
capillary, the path length for light absorbance is small (from Beer’s law: A=εbC, where ε is 
the molar extinction coefficient of the sample, C is the sample molar concentration, and b is 
light path that equals to the capillary diameter) and therefore the detection limits are 
frequently poor and in the range of 10-5 – 10-7 M (2).  
The capillary dimensions lead to injection volumes of a few nanoliters. If the 
injection volume is much larger than 1 % of the total length of the capillary, sample 
overloading occurs and the peaks broaden (3). Without improved detection limits CE 
cannot be used in bioanalytical studies such as analysis of very low levels of steroids in 
biological fluids. The approaches for the enhancement of the detection limits in CE include 
the use of laser-induced fluorescence (4, 5), electrochemical detection (6, 7), and mass 
spectrometry (8) as they allow the low detection limits comparing to UV-visible 
absorbance; chemical derivatization (9); extended length cells in UV-visible absorbance 
detectors (z-cells, bubble cells) (10, 11) and sample enrichment by means of the liquid-
liquid extraction (12), selective membrane extraction (13), and solid phase extraction (14), 
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which are carried out before or after the capillary electrophoresis analysis. However, these 
methods are not directly applicable to the goal of this dissertation. For example, steroid 
molecules are neutral and require the use of MEKC separation which is not directly 
compatible with a mass spectrometer detector due to the non-volatile surfactant molecules 
that contaminate the ionization chamber, reducing the ionization efficiency and 
deteriorating the limits of detection (15). Steroids also lack of chromophores, required for 
LIF analysis, and would therefore need to be chemically modified.  
An in-capillary sample preconcentration method can be a good alternative for 
steroid preconcentration without the use of expensiv  detectors and other modification of 
the instrument or time-consuming derivatization sample pretreatment. The current in-
capillary sample preconcentration techniques are bas d on electrokinetic injection of large 
sample volumes. These techniques combine the sample injection and separation in a single 
capillary and are based on the changes in the electrophoretic velocity of the analytes at the 
boundary between the sample and the running buffer zones. This allows narrowing the 
analyte bandwidth and increasing the amount of the sample that can be loaded into 
capillary leading to a better detection.  
A series of preconcentration techniques used in combination with CE have been 
developed and include: field amplified sample stacking, sweeping, isotachophoresis, pH-
stacking, or chromatographic preconcentration (16, 17). Field amplified sample stacking 
involves ions electrophoretically migrating through a low-conductivity buffer solution into 
a high conductivity buffer solution. The migrating ions slow down dramatically at the 
boundary of the two buffers and preconcentrate (18, 19). Isotachophoresis is performed 
with a discontinuous buffer in which the sample zone is between the background 
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electrolyte of higher (leading electrolyte) and lower (terminal electrolyte) electrophoretic 
mobilities (20). The ionic species are preconcentrated according to the difference in 
mobility by applying an electric field. The preconce tration by pH-stacking occurs at the 
boundary of two buffer solutions of high and low pH(21). Sweeping is based on the ability 
of non-polar analyte molecules to partition into a pseudo-stationary phase (22).  Finally, 
chromatographic preconcentration uses silica beads modified by immobilized ligand which 
captures and preconcentrates a target analyte in-cap llary (23). 
The present chapter discusses the design and performance of two preconcentration 
techniques that were developed for steroid analysis: (1) a chromatographic 
preconcentration by means of a modified silica cartridge integrated in-capillary, and (2) a 
pH-stacking using functionalized cyclodextrins. Both methods can improve the selectivity 
and concentration limits of detection for steroid analysis and enable efficient steroid 
separation analysis in complex mixtures such as blood plasma. Investigation of the 
influence of several parameters that are used to obtain more efficient and more 
reproducible chromatographic separations is also dicussed.  
3.2. EXPERIMENTAL  
3.2.1. CHEMICALS AND MATERIALS 
Carboxymethyl-β-CD, SDS, 3-[cyclohexylamino]-1-propanesulfonic acid (CAPS), 
11-ketotestosterone, and testosterone were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). HPCD was purchased from VWR (West Chester, PAUSA). Steroids, 17β-
estradiol, estrone, 17-hydroxyprogesterone, and progesterone were purchased from 
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Steraloids, Inc (Newport, RI, USA).  17α-ethynyl estradiol was purchased from Cayman 
Chemical (Ann Arbor, MI, USA). Sodium phosphate monobasic salt was purchased from 
Fisher Scientific (Fair Lawn, NJ, USA).  Methanol was purchased from EMD Chemicals 
(San Diego, CA, USA).  Deionized water was purified using ELGA Purelab Ultra (Lowell, 
MA, USA).  Buffered solutions and standard stock soluti n of each sex steroid hormone 
were prepared as described in Section 2.2.1. The running buffer and the samples to be 
analyzed were prepared fresh every day prior to use. 
3.2.2. INSTRUMENTATION 
All CE measurements were carried out as described in Section 2.2.2. Briefly, the 
electropherograms were collected at the wavelengths of UV-light where the analytes 
showed strong absorption (200 nm for estrogens and 254 nm for androgens and 
progesterone). All the separations were performed using 25 µm id, 360 µm od, 30 cm long 
fused silica separation capillary (Polymicro Technologies, LLC, Phoenix, AZ, USA) with 
the detection window positioned 10.2 cm from the cathodic reservoir located at the sample 
inlet. The capillary cartridge and sample trays inside the instrument were maintained at 25 
± 1 ºC while the trays holding the vials filled with the separation buffer were maintained at 
the room temperature which varied from 20 to 24 ºC. All vials containing running buffers 
and samples were treated before analysis as describd in Section 2.2.2.  
3.2.3. CAPILLARY PACKING PROCEDURE 
This type of preconcentration design uses silica beads with an immobilized ligand 
as a preconcentration plug held inside of the separation capillary by a porous frit. The 
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stationary phase captures and preconcentrates the targeted analytes. Silica beads modified 
with hydrophobic alkyl groups are widely used in reversed phase liquid chromatography as 
a packing material for chromatography columns. This material is ideal for strong retention 
of hydrophobic compounds, including steroids, and therefore was utilized in this project. 
A pressure packing technique called slurry packing was used in-house to fabricate a 
capillary with the built-in stationary phase precone tration cartridge similar to a previous 
work by Hoyt and colleagues (24). The polyimide coating was first removed from one end 
of a bare fused silica capillary (26 µm id) using a heating element. To make a temporary 
frit a small amount of silica was then introduced into this end of the capillary by gently 
tapping the end of the capillary into a vial contaiing the silica beads. The temporary frit 
was formed with a heating element. Slurry comprised of stable bond chromatography 
packing material Zorbax SB-C8 with the particle size of 5 micron (Agilent Technologies 
Inc., Santa Clara, CA, USA) and isopropyl alcohol was placed into a closed pressurized 
stainless steel container with two connectors. One of the connectors was attached to a high 
pressure LC system pump while the other one was connected to the fritless end of the 
capillary. After a high pressure had been applied to the capillary, the slurry was introduced 
into the capillary where it was held by the temporary frit while only the liquid component 
passed through. The packed capillary was then succesively flushed with methanol and 
water at 14×103 kPa (2×103 psi). While the capillary was flushed with water the stationary 
phase was gently sintered using commercially available Innova capillary fitting device. 
This procedure resulted in the formation of another frit, which held the stationary phase in 
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place. The temporary frit with the excess of the silica phase was then removed by trimming 
the cartridge to ~ 1 mm length and was used for the further CE experiment. 
3.2.4. CHROMATOGRAPHIC PRECONCENTRATION MEKC PROCEDURE 
Prior to each analysis, the capillary with the chromatographic cartridge was 
sequentially flushed with acetonitrile: water (50: , v/v), water, 0.1 N hydrochloric acid, 
and the separation buffer which was 10 mM SDS in 10 mM phosphate buffered at pH 2.0. 
Acidic conditions were preferred due to the stability of the stationary phase at pH < 6 (25). 
Standard solution of estradiol in methanol was diluted in the mixture of methanol: 
separation buffer (20: 80, v/v) to 60 µM concentration and injected at 69 kPa (10 psi) for 
15 sec onto the activated preconcentrator. The retained steroid molecules were eluted from 
the stationary phase by flushing it with acetonitrile:10 mM phosphate buffered at pH 2.0 
(70:30, v/v) at 17 kPa (2.5 psi) for 1 min and then with the separation buffer only at 6.9 kPa 
(1.0 psi) for 1 min. After elution the sample was analyzed in-capillary by MEKC at 16 kV, 
reversed polarity, and the detection wavelength of 200 nm.  
3.2.5. PH-STACKING MEKC PROCEDURE 
3.2.5.1. The Role of Cyclodextrins  
Several books (26, 27) and a number of articles (28-31) are dedicated to CD host-
guest chemistry. An important characteristic of CDs making them useful is their unique 
ability to solubilize lipophilic molecules in their molecular cavities forming inclusion 
complexes. This is accomplished without formation of chemical bonds and changing the 
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guest molecules structure. The selectivity of this interaction is governed by the size, 
geometry, and physicochemical properties of both analyte and CD. Intramolecular 
interactions occur as the secondary hydroxyl groups at C2 and C3 (see Figure 2.4) can 
form hydrogen bonds. This restricts the free movement of their relative positions, 
maintaining the freedom of motion of the hydroxyl groups (27, 32). The cavity of the 
cyclodextrin is moderately hydrophobic, making it amenable to a wide variety of organic 
guests. Van der Waals and hydrophobic interactions are believed to be the main factors 
involved in complexation (33-36). However, steric effects and hydrogen bonding play a 
role as well (37, 38). The size of the cavity and the CD ring structure is very important. A 
tight spatial fit of the guest is necessary to maxiize the interaction energy due to non-
covalent bonding or allow complexation. Selectivity is determined by the size, structure, 
and physiochemical properties of both the guest and CD. In chromatographic applications, 
the formation of an inclusion complex is beneficial for nonpolar analytes increasing their 
solubility in water. Many groups can be introduced into the CD structure to increase the 
solubility of CDs (39). In this dissertation neutral and charged CD derivatives are used for 
the preconcentration and separation of steroid hormones. 
Carboxymethyl-β-CD was chosen as a preconcentration agent. This compound is 
commercially available and readily soluble in common CE running buffers. 
Sulfobutylether-CD is a popular anionic CD and has igh aqueous solubility. However, it is 
relatively unaffected by pH due to its pKa being too low for stacking at pH 2.5 (40). 
Additionally, this material is more expensive and multiple labeled sulfobutylether-β CD 
can lead to peak broadening since the electrophoretic mobility changes with the degree of 
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substitution.  CMCD molecules form inclusion complexes with steroids in aqueous 
solutions (41, 42). Kano and co-workers (43) reported an apparent pKa of ~ 5 for 2,3-di-
O-carboxymethyl-β-CD (25 ºC, 0.1 M NaCl). The pKa of CMCD is suitable for stacking 
a sample prepared in a basic medium and injected in a capillary filled with acidic running 
electrolyte. In the basic solution carboxylic groups surrounding CMCD molecule will 
become deprotonated thus making the entire molecule be negatively charged which 
allows electrokinetic injection into the separation capillary. Alternatively, while in the 
solution with low pH the carboxylic groups will be protonated back producing neutral 
CMCD molecule (Figure 3.1). Some physical and chemical properties of CDs used in the 




Figure 3.1. Dissociation of CMCD molecule depends on pH of the solution. 
Table 3.1. Cyclodextrins used in the research. 
CD 
Solubility in water, g/100 
mL MW  AVE -R 
β-CD 1.8 1135 -H 
Carboxymethyl-β-CD 5.0 1541 -CH2COOH 
Hydroxypropyl-β-CD 
 




3.2.5.2. Stacking Mechanism 
Steroid standards prepared in methanol were diluted to desired concentrations with 
an aqueous solution comprised of 1 mM CMCD in 50 mMCAPS buffered at pH 10.  The 
concentration of methanol in the final sample was 5 % to aid the dissolution of a 
hydrophobic steroid. The running buffer comprised of 30 mM SDS, 13 mM HPCD in 200 
mM phosphate buffered to pH 2.5. No methanol was added to the running buffer.  
The capillary was first filled with the running buffer followed by the injection of a 
deionized water plug at 13.8 kPa (2 psi) for 6 sec. The steroid sample was then injected 
electrokinetically upon application of 10 kV high voltage at reversed polarity for 60 sec. 
The neutral steroid molecules carried by the CMCDs which are fully deprotonated 
(negatively charged) at high pH were driven into the separation capillary. Once in contact 
with the acidic running buffer, the neutral steroid-CD complex concentrated in a narrow 
zone at the pH junction. The negatively charged SDS micelles migrated as a function of 
electrophoretic mobility towards the anode, which was located past the detection window.  
The velocity of the neutral HPCD was insignificant s the EOF was suppressed (see Fig. 
3.2-A). Following stacking, the reverse polarity run at 16 kV was started and the separation 
was initiated by replacing the sample vial with a cathodic reservoir containing 30 mM SDS, 
13 mM HPCD in 200 mM phosphate buffered at pH 2.5. (Figure 3.2).  The steroids 
partitioned or associated competitively with the SDS and CDs and were separated as 




Figure 3.2. Schematic representation of pH-stacking using functio alized cyclodextrin.  
3.2.5.3. Capillary Flushes  
A special preconditioning and washing sequence was performed on each capillary 
to ensure more reproducible separation conditions. At the beginning of each day the 
capillary was conditioned with several timed flushe at 172 kPa (25 psi).  The sequence of 
these flushes was 5 min methanol, 5 min water, 25 min 0.1 N hydrochloric acid, 5 min 
water, 25 min running electrolyte comprised of 30 mM SDS 13 mM HPCD, 200 mM 
phosphate buffered at pH 2.5.  In between runs the capillary was flushed at 172 kPa (25 
psi) for 2 min with the running electrolyte. The methanol was used to rinse the capillary 
interior after steroid stacking analysis. To suppress the ionization of the silica surface 
silanol groups and as a result the EOF 0.1 N hydrochlori  acid was used. The water was 
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used to remove any excess of the Cl¯  ions and finally the capillary was filled with the 
running electrolyte used for the separation.     
3.3. RESULTS AND DISCUSSION 
3.3.1. CHROMATOGRAPHIC PRECONCENTRATION OF STEROIDS  
The chromatographic preconcentration by means of revers d-phase silica gel beads 
forming an in-capillary preconcentration plug was investigated and demonstrated good 
concentration enhancement despite several procedural limitations. In the following 
experiment the acidic separation buffer was used and the steroid separation was optimized 
at acidic conditions under suppressed EOF due to the preferential use of silica packing 
material stable at low pH for the fabrication of the preconcentration cartridge. The 
preconcentrator used in this study is schematically illustrated in Figure 3.3. 
Figure 3.4 shows electropherograms obtained for the MEKC separation of the 60 
µM 17β-estradiol with and without the in-capillary chromatographic preconcentration step. 
The represented data confirms that the use of the solid phase preconcentrator produces 
higher estradiol peak while keeping its width small. The injection of the same sample at the 
same conditions without the preconcentrator results in a broad and short sample peak, 
significantly degrading the separation efficiency. The injected sample volume using the 
plug was approximately 75 times larger comparing to the volume of the sample injected 
using conventional MEKC under acidic conditions. This number was estimated by 
comparing the injection time and pressure used for acidic MEKC and chromatographic 
preconcentration MEKC in this work. However, while conducting this study it was noticed 
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that after just a few days of use the preconcentrator plug could be easily pushed out of its 
place and out of the separation capillary with the applied pressure. The biggest technical 
issue of this technique was the sensitivity of the pr concentrator to the storage conditions 
and incompatibility with the solvents used. Because of these technical difficulties, pH-
stacking was tested as an alternative preconcentration method which could be integrated 
into a CE instrument without interfering with the automation (44-46). 
 
 






Figure 3.4. Electropherograms of a blank sample and  






3.3.2. PH – STACKING OF STEROIDS  
Stacking can be used for charged and neutral compounds, such as steroid hormones. 
The effective mobility of weak acids and bases in the capillary is a function of pH. This 
mode of stacking utilizes a pH junction formed at the boundary of two buffer zones, when 
the buffer solutions of low and high pH values are introduced into a separation capillary. 
The analyte preconcentration at the pH junction is referred to as pH-stacking (Fig. 3.5). The 
efficiency of pH-stacking depends on the pH of the solutions, the concentration of the 
sample matrix, as well as the pKa of the stacked molecule.  
 
Figure 3.5. Formation of pH-junction at the interface of two, basic and acidic, buffer solutions. 
Preconcentration by pH-stacking can be carried out using modified cyclodextrins. 
Only a few papers reported stacking preconcentration prior to MEKC separation of neutral 
steroids. Quirino and colleagues (47) demonstrated up to a 280-fold stacking enhancement 
for steroid determination using on-line sample preconcentration that was accomplished by 
using stacking and sweeping under pH-suppressed EOF in the presence of sulfated β-
cyclodextrin. Urban and co-workers (48) studied the separation of three anabolic steroids 
(methyltestosterone, methandrostenolone and testostrone) using charged CD derivatives 
and online reverse migrating sample stacking with large-volume injection followed by 
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MEKC with UV-visible absorption. The detection limits obtained for these compounds 
were approximately 2.8×10–7 – 5×10–5 M while the sensitivity enhancement factors were in 
the range from 100 – 190. In another report by Munro and co-workers (40) sweeping 
afforded detection of approximately 430 nM estrone a d estradiol (S/N 55) using a 99 s 
hydrodynamic injection of steroids in sulfated β-CD followed by separation using an 
aqueous separation buffer comprising borate, phosphate, cholate, and acetonitrile. Britz-
McKibbin and colleagues (49) demonstrated over a 100-fold enhancement using a 
dynamic pH junction-sweeping preconcentration with borate and γ-CD. In the present 
work, pH-mediated stacking of anionic steroid-CD complexes followed by MEKC 
provides at least a 500-fold enhancement in detection l mit over hydrodynamic 
introduction of native steroids. The separation targets were progesterone, 
hydroxyprogesterone, 11-ketotestosterone, estrone, estradiol, and ethynyl estradiol. These 
analytes vary in CD affinity and therefore served as a model sample set to demonstrate 
the possibility of quantitative analysis following sample stacking by means of CD 
inclusion for molecules with different molecular characteristics.  
The selectivity toward the targeted steroids requires a proper balance between the 
SDS and CD.  Under reversed polarity, the androgens and progesterone used in this study 
migrate faster than estrogens as they have higher affinity to SDS micelles.  Changes in the 
CD concentration affected the separation time and resolution.  For example, using 30 mM 
SDS and 18 mM HPCD, progesterone, hydroxyprogesterone, and 11-ketotestosterone were 
baseline resolved in less than 5 minutes, but the migration times of the remaining estrogens 
increased and the peaks broadened substantially.  Running electrolyte comprised of 30 mM 
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SDS and 10 mM HPCD degraded the resolution of progesterone, hydroxyprogesterone, and 
11-ketotestosterone, but resulted in the baseline resolution of estrone, estradiol, ethynyl 
estradiol in under 5 minutes.  The electropherogram shown in Figure 3.6 was obtained 
using running buffer comprised of 30 mM SDS and 13 mM HPCD.  The run was finished 
in less than 5 minutes.  Sample stacking with the procedure described in Section 3.2.5 was 
not affected by varying degree of carboxymethyl substitution, as there was no change in the 
overall charge for CD under the loading at pH 10 no during stacking at pH 2.5.   
 
Figure 3.6 displays superimposed electropherograms resulting from stacking and separating the blank (solid) 
and sample containing 6 steroids (dot). Data was collected at 254 nm and 200 nm.  The analytes are labeled as 
follows: P – progesterone, HP – 17-hydroxyprogesterone, E1 – estrone, 11KT – 11-ketotestosterone, EE – 
17α-ethynyl estradiol, E2 – 17β-estradiol. Separation conditions are summarized in text. Reproduced with 




Figure 3.7 displays the background subtracted electropherograms of 6 steroids following analyte stacking.  
The electropherograms were collected simultaneously ing PDA detection. The analytes are labeled as 
follows: P – progesterone, HP – 17-hydroxyprogesterone, E1 – estrone, 11KT – 11-ketotestosterone, HP – 
17α-ethynyl estradiol, E2 – 17β-estradiol.  Peaks labeled * are an artifact resulting from the background 





3.3.2.1. STACKING EFFECTED BY CONDUCTIVITY OF THE WATER PLUG 
A CE or MEKC analysis comprises three steps: (1) flushing the capillary with the 
separation buffer of a certain pH; (2) the sample inj ction, and (3) the electrophoresis of 
the analytes. In CE the electric potential applied across the separation capillary causes the 
ions in the solution to migrate generating the electric current flow. The ability of an 
aqueous solution to conduct the electric current depends on the concentration of the salts 
dissolved in water and is called a conductivity. Highly concentrated solutions are more 
conductive than those with the lower contents of free ions and therefore less resistant. 
Conductivity of very dilute solutions can be described by Kohlraush law (50) which sums 
the conductivity contributions of all ions in the solution:  
( )ii C⋅Σ⋅=Λ λρ                                                              (3.1) 
where Λ is conductivity, ρ  is density of water, λi and ci are equivalent ionic conductance 
and concentration of an ion ‘i’ respectively. On the other hand, the conductivity of a 
solution is inversely proportional to the electric filed (Equation 3.2) and to resistivity 
(Equation 3.3):  
J = σ ⋅ E  (3.2) 
where J is the current density and E is the electric field strength.  
ρ
σ 1=  (3.3) 
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In order to accomplish better stacking in the present method, a water plug was 
introduced into the separation capillary immediately after filling it with the phosphate 
buffer and right before the sample injection. As a result, the low conductivity should 
provide an ion-vacant region to concentrate negative ions deeper into the capillary away 
from the injection point as well as ensure proper enhancement of the electric field at the 
injection point. The higher electric field, in turn, i creases the electrophoretic velocity of 
the anionic CMCD molecules (Equation 2.1) which arry the neutral steroid analytes 
injected electrokinetically into the capillary water zone toward the pH-junction 
preconcentration boundary.  
In this experiment, in the beginning of each CE run the capillary was rinsed at 172 
kPa (25 psi) for 2 min with the running buffer. Then a water plug was hydrodynamically 
injected by 14kPa (2 psi) pressure for 13.5 sec, 6 sec, and 0 sec right before the sample 
injection performed for durations of time: 5, 10, 2, 40, 60, and 80 sec.  
According to Fig. 3.8, stacking was not affected by the conductivity of the water 
plug in contrast to previous works (51, 52). In fact, the effectiveness of the sample 
stacking did not depend on the presence or the absence of the water plug in the capillary. 
However, to provide a small ion-free region for thestacked sample a water plug injected 
for 6 sec was used in the further studies. The length of the water plug injected for 6 sec 
was measured to be 5.5 mm or 5.4 % of the effective apillary length. This measurement 
was conducted by injecting the water at 2 psi into the capillary containing the running 




Figure 3.8. The effect of water plug on sample stacking. Plot of the peak area versus sample injection time. 
Sample was injected electrokinetically at 8 kV and was 400 µM ethynyl estradiol in 10 mM CMCD, 5% 
methanol, 50 mM CAPS buffered at pH 10. BGE was 30 mM SDS, 10 mM HPCD in 50mM phosphate 
buffered at pH 2.5. Separation: at 16kV and normal polarity. Water plug injection: 2 psi 13.5 sec (      ), 2 psi 6 
sec (      ), no plug (      ) 
3.3.2.2. STACKING TIME OPTIMIZATION 
CE separation is affected by the length of the injection plug. This is because the 
longer the sample plug the broader the peak in the resulted electropherogram.  Sample 
preconcentration by pH-mediated stacking provides a way to concentrate sample molecules 
in a narrow zone at the boundary of two buffer soluti ns of different pH values allowing 
the increase of the injection time without sacrificing the efficiency. Using electrokinetic 
injection, charged ions can be easily introduced into the capillary as a result of their 
electrophoretic migration (53, 54).   
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As mentioned earlier all CE measurements were conducte  using a Beckman 
Coulter P/ACE MDQ capillary electrophoresis instrument (Beckman coulter, Fullerton, 
CA, USA). This instrument is fully automated and managed using 32 Karat™ v7.0 
Software. The software provides numerous control and alysis functions allowing 
programming various capillary electrophoresis runs. The programming option of the 
instrumental software allows injecting sample with the voltage of up to 10 kV for no longer 
than 99.9 sec. Both options allow controlling the duration to reach the injection voltage, so 
called “ramp time”. However, while in the separation ption a desirable ramp time has to 
be set, the injection option compensates the ramp ti e automatically, therefore the precise 
injection time is known. In this work the injection voltage was selected to be 10 kV as it’s 
the highest possible voltage that can be applied by the instrument for the electrokinetic 
injection. However, in order to determine the optimal injection duration that would provide 
the best sample signal, the limited timing conditions needed to be exceeded. To increase the 
injection time limits the separation option available in method programming was used. 
With this option a sample can be injected for the infin te duration of time.  
The following set of experiments uses only one steroid, ethynyl estradiol, a 
potential endocrine disruption compound and a component of birth control pills. The 
concentration of ethynyl estradiol in 1 mM CMCD sample was 10 µM. The data obtained 
with the use of the injection option correlates with the data measured using the separation 
option for sample injection which is demonstrated in F gure 3.9. A 60 sec injection was 
chosen to be the optimal duration despite the maximum sample stacking being obtained 
with the injection at 10 kV for 70 sec. The further increase in the duration time of the 
88 
 
sample injection resulted in lower sample stacking. This can be due to the fact that longer 
injection durations can lead to the EOF formation in the water region of the capillary which 
will slowly drag the CMCD anions toward the cathode located at the inlet and therefore 
away from the pH-junction and even out of the capill ry back to the sample vial. The 70 
sec injection however, resulted in the splitting of ethynyl estradiol peak due to the sample 
overloading. Injection plug lengths longer than the diffusion contr lled zone width will 
proportionally broaden peak width and in extreme cases distorted peak shapes, peak 
broadening and peak splitting is observed (55). The appearance of the peak splitting can 
be due to sample overloading, or electromigration dispersion, that can occur due to the 
differences in the electric field between the sample and the separation buffer if the plug is 
too wide (56). In this study a water plug was introduced in the capillary before the sample 
was injected. This created a capillary region with high electric field comparing to the 
region of the capillary filed with the separation buffer containing SDS and HPCD. As 
mentioned earlier upon application of the injection voltage both anionic CMCD carrying 
steroids and SDS micelles present in the capillary would start moving toward the anode. 
However, because of the high electric filed in the water filled region, CMCD anions will 
migrate much faster toward the pH-junction were they will be slowed down and 
preconcentrated. At the same time some steroids can exchange into micellar phase 
located on the other side of the pH-junction and start moving toward the outlet. If the 
injection duration is short, the SDS micelles enteri g the capillary upon application of the 
separation voltage will move faster toward the stacking zone where they will catch up the 
micelles which have already moved toward the outlet with steroids reached the junction 
during the first seconds of the stacking injection. If the injection time is too long, the 
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micelles entering the capillary will be separated by a longer distance from the first 
micellar band carrying the steroids. Therefore a split peak will appear in the resulting 
electropherogram.  
The peak areas were used for signal quantitation as they provided longer dynamic 
ranges comparing to the peak heights. The increases in peak heights were not linear as the 
sample concentration increased due to the band broaening effects.  
 
 
Figure 3.9. Stacking enhancement versus injection time. Sample injected electrokinetically at 10 kV by 
injection (blue) and separation (red) options in the instrument method programming. Sample is 10 µM ethynyl 
estradiol in 1 mM CMCD, 5% methanol, 50 mM CAPS buffered at pH 10. BGE is 30 mM SDS, 13 mM 




3.3.2.3. The Effect of CMCD Concentration on Stacking Efficiency 
The use of charged CMCD for steroid stacking is attrac ive as it requires no 
chemical derivatization of steroids. The effect of the addition of CMCD to the sample 
solution and its effect on the stacking enhancement are demonstrated in Figure 3.10, that 
plots the estradiol peak area versus CMCD concentration in the sample buffer. The 
studies confirmed that the maximum stacking was obtained with the use of 1 mM 
carboxymethyl-β-CD. The further increase of CMCD concentration decreased the signal 
area as seen in the Figure 3.11.   
There are a few reasons for lower stacking at the higher CMCD concentration. 1) 
As the concentration of CMCD increases, there is higher chance of injecting empty 
CMCDs into the capillary due to their higher electrophoretic mobility comparing to those 
CDs carrying steroids. Therefore fewer steroids will be preconcentrated at the pH-
junction. 2) It is known from the literature that CD-steroid complex is mostly 1:1 ratio, 
although 2:1 complex formation can take place as well (57). If this were the case, one 
steroid molecule would be “locked up” by two CD molecules and this would affect the 
interaction with SDS micelles which serve to remove steroids from the stacking zone and 
carry them toward the detection window. 3) Finally, as the concentration of CD increases 
compared to the concentration of SDS in the running buffer, the equilibrium will be 
shifted toward the formation of the steroid-CD complex as discussed in Section 2.3.4 and 
away from incorporation into micellar phase, therefo  decreasing the steroid detection 
response. The steroid concentration in the sample does not determine the optimal 
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concentration of CMCD if increased from 500 nM to 10 µM that still provides the best 
stacking efficiency using 1 mM CMCD. Based on these observations 1mM CMCD was 
chosen as the optimal concentration for better stacking efficiency.  
 
 
Figure 3.10. Stacking enhancement versus CMCD concentration in the sample buffer. Sample is 1 µM 
estradiol in CMCD, 5% methanol in 50 mM CAPS, pH 10. Running buffer: 30 mM SDS, 13 mM HPCD in 





Figure 3.11. Representative electropherograms of the stacking enhancement versus CMCD concentration in 
the sample buffer. CMCD in the sample: A – 5 mM, B – 2 mM, C – 1 mM, peak labeled as * - 1 µM estradiol,  
3.3.2.4. Stacking versus Phosphate Concentration 
Figure 3.12 shows the importance of adjusting the concentration of phosphate 
buffer for improving of the stacking efficiency. Since phosphate was used for the 
preparation of the running buffer, it was important to maintain not only a particular and 
constant pH but also a proper buffer capacity for the reproducible separation. Buffer 
concentration has a significant effect on the EOF because it changes the ζ-potential on the 
capillary wall. As the concentration of the buffer increases, the ionic strength increases as 
well, thus lowering ζ-potential and EOF. Moreover the higher the ionic strength of the 
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buffer in use the more chance of getting Joule heating effect in the capillary due to high 
separation currents. In the present case, EOF was suppressed because the surface silanol 
groups were protonated at the low pH of the separation buffer. However, it was necessary 
to find out how large a phosphate concentration could be used without causing excessive 
Joule heating.  
The separations were performed in the presence of 50, 75, 100, 150, and 200 mM 
phosphate buffered at pH 2.5 containing 30 mM SDS and 13 mM HPCD. The sample was 
10 µM ethynyl estradiol injected at 10 kV for different durations of time 50, 60, 70, 80, and 
90 sec. The use of 200 mM phosphate produced the best stacking effect measured in the 
peak area as shown in the figure below. The 60 sec sample injection was still the most 
advantageous since the longer sample injections produced distorted electropherograms due 




Figure 3.12. Stacking enhancement versus concentration of phosphate buffer and sample injection time. 
Sample injected electrokinetically at 10kV. Sample is 10 µM ethynyl estradiol in 1 mM CMCD, 5% 
methanol, 50 mM CAPS buffered at pH 10. BGE is 30 mM SDS, 13 mM HPCD in phosphate buffered at pH 
2.5. Separation: at 16kV and normal polarity. 
3.3.2.5. Stacking versus Methanol Concentration in Sample Matrix  
The effect of added methanol on stacking enhancement was investigated by 
increasing the volume fraction of methanol (0.1, 1, 2, 5, 7, 9, 10, 15, 20, 30, 50 %, v/v) in 
the sample containing 1 µM estradiol in 1 mM CMCD, 50 mM CAPS at pH 10. The plot of 
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the peak area measured for preconcentrated estradiol versus the percentage of methanol in 
the sample is illustrated in Figure 3.13. It is evid nt that the formation of steroid-CMCD 
inclusion complex takes place even in the absence of methanol in the sample. The addition 
of 5 % methanol increases the peak area by 6 % versus the area for the sample without 
methanol. The results show that the further increase of the methanol amount in the sample 
shifts the equilibrium away from the formation of CM D-steroid inclusion complex, thus, 
lowering the stacking efficiency.  
  
 
Figure 3.13. Stacking enhancement versus methanol content in the sample buffer. Sample is 1 µM estradiol in 
1 mM CMCD, methanol, 50 mM CAPS, pH 10. Running buffer: 30 mM SDS, 13 mM HOCD in 200 mM 
phosphate, pH 2.5. Injection performed electrokinetically at 10 kV for 60 sec. Separation performed at 16 kV 




3.3.2.6. Stacking versus pH of the Sample Buffer  
An effective preconcentration by means of pH-stacking depends on the pH of the 
buffer solutions used to create the pH-junction andmore importantly on the pKa of the 
analyte to be preconcentrated. As mentioned earlier, CMCD used for stacking 








+=  (3.4) 
CMCD is expected to be fully (100%) deprotonated at pH = 7, and fully protonated at pH = 
3. To completely suppress EOF, the pH of the running buffer must be less than 3. Only 
phosphate (pKa ~ 2.1) was suitable for being used at pH < 3. The sample containing 
steroids was prepared in 50 mM MOPS buffer at pH 7 and subject to stacking procedure as 
described in Section 3.2.5. The results demonstrated stacking enhancement for the steroids 
as expected (see Fig. 3.14-A). However a 10 times better stacking enhancement was 







Figure 3.14. Stacking enhancement versus pH of the sample buffer. Sample contains 10 µM progesterone, 
testosterone and androstenedione in 5 % methanol, 1 mM CMCD, and A – 50 mM MOPS, pH 7.0; B – 50 
mM CAPS, pH 10. C – measured for 1 µM progesterone, testosterone and androstenedione in 5% methanol, 1 
mM CMCD in 50 mM CAPS, pH 10. Injection performed for 60 sec at 20 kV.  
 
3.3.2.7. Stacking Enhancement  
In capillary electrophoresis, sample injection at high injection parameters (voltage 
and pressure) typically leads to band broadening (2). The developed stacking method 
allows to use longer injection time without sacrifiing separation efficiency. The advantage 
of the developed stacking method is demonstrated in Figure 3.15 by comparing the upper 
trace (stacked for 60 seconds) with the lower trace (injected electrokinetically for 2 
seconds). Enhancement in limits of detection for each steroid was calculated by dividing 
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the LOD obtained by means of stacking-CE by the LOD obtained with the use 
conventional MEKC and hydrodynamic injection. 
For stacking-CE analysis the limits of detection were measured at a signal-to-noise 
ratio of 3. The signal and noise were determined as the peak height and the standard 
deviation of the baseline respectively. LODs were measured at 200 nM progesterone (n=9), 
200 nM hydroxyprogesterone (n=6), and 500 nM ketotes sterone (n=7), 50 nM estradiol 
(n = 9), 70 nM estrone (n=10) and 70 nM ethynyl estradiol (n=7). Each sample containing 
only one steroid was prepared in 1 mM CMCD, 50 mM CAPS, pH 10 and was analyzed by 
stacking-MEKC as described in Section 3.2.5. The limits of detection for conventional 
MEKC analysis of steroids were calculated by the same principle. A series of samples 
containing 50 µM concentration of each steroid were prepared in the running buffer (30 
mM SDS, 13 mM HPCD in phosphate, pH 2.5, 5% methanol) and injected at 0.5 psi for 3 
sec. The peak areas were measured and used for stacking enhancement evaluation. The 
calculated enhancements in limits of detection are represented in Table 3.2. The stacking-
MEKC method demonstrated at least 350-fold up to 1100-fold improvement in LODs over 





Figure 3.15. Sample containing 500 nM estrone (E1), ethynyl estradiol (EE), and estradiol (E2) is injected at 
10 kV, for 60 s (upper trace) or 2s (lower trace) in 1 mM carboxymethyl-β-CD diluted in 50 mM CAPS 
buffered at pH 10.  The electropherogram is obtained using 30 mM SDS, 13 mM HPCD, 200 mM phosphate 
buffered at pH 2.5. Reproduced with permission from (58). 
 
Table 3.2. Enhancement in limits of detection for steroids measured by stacking-CE injected 
electrokinetically versus conventional MEKC with hydrodynamic injection.  






  nM  mM   
1  progesterone  7.1  5.3  746  
2  hydroxyprogesterone  15  5.3  353  
3  dihydroxyprogesterone   11  4.7  427  
4  testosterone  4  3.5  875  
5  estrone  3.1  2.1  677  
6  11-ketotestosterone  14  5.9  421  
7  ethynyl estradiol  4.7  2.2  468  
8  estradiol  2.9  3.2  1103  
      
For experimental conditions see text. 
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3.3.2.8. Stacking Figures of Merit 
This section outlines the figures of merit that demonstrate the effectiveness of the 
developed and optimized stacking approach. Figures of merit (Table 3.3) were obtained 
using a 10 kV 60 second stacking injection and a separation buffer containing 13 mM 
HPCD, 30 mM SDS in 200 mM phosphate buffered at pH 2.5.  The baseline in the 
electropherograms that results from sample stacking had some distortion (see for example 
Figure 3.7).  The data shown in Figure 3.7 were obtained from successive runs of a sample 
and blank and subsequently processed using a spreadheet program. 
For all steroids, the within-day and day-to-day reproducibility in migration time 
was ≤ 1 % RSD and ≤ 2 % RSD, respectively.  The within-day and day-to-day 
reproducibility in peak area was ≤ 9 % and ≤ 22 % RSD, respectively. The day-to-day 
reproducibility was affected by the variations in room temperature from 20 to 24 °C, 
which changes the solubility of the steroid in carboxymethyl-β-CD. Although a dedicated 
thermostat was not available at the time of measurements, the use of calibration curves 
within-day almost completely circumvents this issue due to reasonable temperature 
stability during the day. 
Linear ranges were determined from nine calibration curves (3 per day for 3 days) 
and measured at 0.50 µM hydroxyprogesterone, estrone, ethynyl estradiol and estradiol, 
0.75 µM progesterone, 11-ketotestosterone.  The curves were m asured simultaneously for 
6 analytes. Detection was performed by UV-visible absorbance at detection wavelength of 
254 nm for progesterone (R2 ≥ 0.98), hydroxyprogesterone (R2 ≥ 0.97), and 
ketotestosterone (R2 ≥ 0.99), or 200 nm for estradiol (R2 ≥ 0.99), estrone (R2 ≥ 0.98), and 
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ethynyl estradiol (R2 ≥ 0.99). The data from individual curve fitting are shown in Table 3.3.  
Under the experimental conditions, calibration curves for steroids with high β-CD affinity 
(estradiol, ethynyl estradiol, and estrone) are easily obtained in the range from 250 – 
10,000 nM.  Progesterone, 11-ketotestosterone, and hydroxyprogesterone were measured at 
254 nm to maximize absorbance.  By using a photodiode array, all steroids were detected 
within a single run.  The different detection wavelength and lower β-CD affinity of 
progesterone, 11-ketotestosterone, and hydroxyprogesterone resulted in higher limits of 
detection and a smaller concentration range of linear response. Finally, 
hydroxyprogesterone formed a split peak, especially t higher concentrations.  This 
splitting of hydroxyprogesterone may result from stereoisomers or from multiple 
complexation equilibria with carboxymethyl-β-CD.    
 
Table 3.3.  Stacking - MEKC Figures of Merit  
   Reproducibility  
Steroid LOD (nM) Linear 
Range (µM)   
Within day (n=10)   Day-to-day (n= 3) 
Time (min) Area (x103)   Time (min) Area (x103) 
progesterone  7.1 ± 0.7 0.25 – 1.0 2.47 ± 0.01 1.38 ± 0.07  2.49 ± 0.02 1.36 ± 0.05 
hydroxy-
progesterone  




3.1 ± 0.8 
 
0.25 - 5.0 
 
3.55 ± 0.03 
 
5.2 ± 0.5 
  
3.61 ± 0.06 
 





14 ± 3 
 
0.50 - 10. 
 
3.68 ± 0.03 
 
1.5 ± 0.1 
  
3.74 ± 0.07 
 




4.7 ± 0.4 
 
0.25 – 10. 
 
4.21 ± 0.03 
 
7.6 ± 0.5 
  
4.30 ± 0.08 
 




2.9 ± 0.6 
 
0.25 - 5.0 
 
4.39 ± 0.04 
 
8.9 ± 0.5 
  
4.5 ± 0.1 
 






A preconcentration technique using the chromatographic preconcentrator 
positioned in-capillary for enhancement of the detection limits for steroid analysis by CE 
has been demonstrated. The benefit of this preconcentration approach is the possibility to 
inject a much larger sample volume opposed to conventional CE or MEKC while 
maintaining a high efficiency separation. However, the technical limitations of this method, 
the resulting low reproducibility and very sophistica ed packing procedure preclude its 
application in systematic and high throughput screening of steroid hormones required to 
detect endocrine disruption. 
In contrast, a newly developed pH-mediated stacking MEKC method for the 
preconcentration of selected sex steroid hormones demonstrated outstanding performance 
and stacking efficiency exceeding two orders of magnitude with targeted steroids. The 
analysis of parameter space revealed that the increased amount of CMCD and methanol in 
the sample buffer result in lower stacking efficieny. However, the high concentration of 
the running buffer improves the stacking. The within-day and day-to-day reproducibility of 
this method, and the low limits of detection justify its promise for the determination of 
steroids in fish plasma samples which will be presented in chapter 4. 
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In the previous chapter, a newly developed pH-mediat  stacking MEKC method 
for analysis of sex steroid hormones was evaluated using aqueous solutions prepared from 
steroid standards, and demonstrated reproducible performance and low limits of detection. 
To fully demonstrate the applicability and efficiency of the method in endocrine disruption 
studies, it was required to apply the method to real-lif  samples such as wild fish blood or 
plasma. Two major challenges in this analysis are the small volume of the fish plasma and 
the presence of interfering compounds, which obstruct he CE separation.  
The fish have long been used as biosentinel models of water quality in biological 
studies, mainly because of the concerns associated wi h the increased production, use, and 
disposal of chemicals in the environment (1-3). Both, the wild fish and the fish exposed to 
pollutants in a laboratory can provide valuable information for studying the effects of 
endocrine disruption. The fish acquires EDCs via the gills, skin, and the diet, including 
plants and smaller invertebrates, which in turn accumulate pollutants from the water or 
sediments during their lifecycle. The physiological system of the fish is similar to 
mammals, including humans, and many of the pollutant-induced disorders are likely to 
have similar effects. The reproductive endocrine system is particularly similar within the 
vertebrates (4). Furthermore, the accumulation of pollutants in the muscle of the edible fish 
has clear implication for the human health.  
 Recent effort has focused on the “environmental estrogens” – industrial chemicals 
that may mimic natural estrogens.  EDCs affect the estrogen receptor in the fish, as well as 
the metabolism or catabolism of sex steroids, thus primarily disrupting the fertility of the 
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fish. Suppressed reproduction and signs of feminization in the male fish, as well as sexual 
dimorphism (differences in the body appearance based on sex), are mainly due to 
estrogenic hormones such as 17β-estradiol, estrone, and ethynyl estradiol, or hormone 
mimics (5, 6). The concentration of estrogenic steroids in the aquatic environment ranges 
from 0.010 ng/L to 7.0 ng/L (7, 8). Steroid estrogens can be harmful for the fish at a 
concentration as low as 2.0 ng/L (9).  
Several factors must be considered when using fish to test for effects of EDCs. The 
temperature, photoperiod, diet, availability of spawning substrates, proximity and 
reproductive readiness of the potential mates, and the water quality all affect the 
reproductive status, ovulation, and spawning in fish (2). Seasonal and daily changes in sex 
hormone levels must be considered in sampling schemes because there can also be a 
significant contribution of extrinsic factors, such as the stress from capture, handling and 
confinement which have a rapid effect on the sex hormone levels in the fish blood plasma 
(10). The fish species desirable for EDC analysis should be easy to breed and handle in the 
laboratory, readily available year round, widespread, and economically feasible. Finally, it 
is important to choose species with the well-studied reproductive biology.  
Endocrine disruption in fish can be monitored using physical and chemical 
biomarkers. Disrupted fertility of fish can be evaluated by the number and viability of the 
eggs, fertilization, the survival of the offspring, the physiological abnormalities in size and 
growth, and histology (the anatomical study of the microscopic structure of animal tissue). 
Vitellogenin has been used as a biomarker for exposure to anti-estrogenic compounds in 
several fish studies (11-16). Vitellogenesis is the process in which the vitellogenin, a 
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female egg protein, is synthesized by the liver in esponse to endogenous estrogen and 
then absorbed by growing oocytes, where it provides nutrition for the developing 
embryos (17). Plasma vitellogenin concentrations increase during sexual maturation of 
female fish (18), and can reach tens of milligrams per milliliter in some species. In 
contrast, the concentration of the endogenous estrogen in male fish is too low to trigger 
the expression of the vitellogenin gene therefore very little vitellogenin can be detected in 
male fish (19). However, vitellogenesis can be induced if the male fish is exposed to 
various concentrations of natural and synthetic estrogens present in water (20). For 
example, 0.1 ng/L of 17α-ethinylestradiol can cause a significant increase in the plasma 
vitellogenin concentration after a relatively brief xposure (21, 22). Although the high 
levels of vitellogenin can be related to endocrine disruption, it is essential to control the 
levels of sex steroid hormones in plasma. This can determine whether the high 
concentrations of vitellogenin in male or immature female fish were caused by exogenous 
EDCs and not by the endogenous secretion of 17β-estradiol, and whether the presence of 
estrogenic EDCs had a negative effect on endogenous steroid secretion (23).   
It has been mentioned earlier that the reproduction in teleost, as in vertebrates, is 
controlled by the brain-pituitary-gonodal axis (Section 1.1.4.). In male teleost, 11-
ketotestosterone and testosterone are the most important androgens that control a variety of 
reproductive processes (24-27). Estradiol, in turn, is the primary female estrogen in charge 
of gonodal development while α,β-dihydroxyprogesterone is responsible for final 
maturation of teleost oocytes (28, 29). The four steroids were therefore selected to help 
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identify and study the occurrence of intersex triggered by endocrine disruption and to 
monitor reproduction in the fish.  
In the present chapter, the complex composition of the plasma samples required the 
development of a sample purification procedure for ste oid extraction prior to the stacking 
preconcentration and CE separation. Four different fish species: catfish (Ictalurus 
punctatus), smallmouth bass (Micropterus dolomieu), largemouth bass (Micropterus 
salmoides), and yellow perch (Perca flavescens) were used in order to ensure that method 
can handle the differences in the blood samples from different fish. An improved three-step 
extraction procedure, introduced here for the first time, allows for the separation of the 
endogenous steroids from fatty acids and highly lipophilic interferences such as cholesterol 
prior to CE-analysis. The method is applicable for v lume-limited plasma samples.  
Finally, the optimized sample preparation procedure followed by pH-mediated 
stacking MEKC was applied to the analysis of endogen us steroids in plasma of the yellow 
perch (Perca flavescens) captured from natural aquatic environments. The results were 
obtained with an external standard calibration curve and compared to the results measured 
by means of the standard addition method. The developed method was validated by 
measuring the recoveries of the standard steroids ad ed to fish plasma before extraction. 
The steroid levels quantified in yellow perch plasm were also measured and compared to 




4.2.1. CHEMICALS AND MATERIALS 
CMCD, SDS, 3-[cyclohexylamino]-1-propanesulfonic acid (CAPS), 11-
ketotestosterone, and testosterone were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). HPCD was purchased from VWR (West Chester, PAUSA). Steroids, α,α-
dihydroxyprogesterone, α,β-dihydroxyprogesterone, 17β-estradiol were purchased from 
Steraloids, Inc (Newport, RI, USA).  Sodium phosphate monobasic salt was purchased 
from Fisher Scientific (Fair Lawn, NJ, USA).  Methanol was purchased from EMD 
Chemicals (San Diego, CA, USA).  Ethyl acetate was purchased from Mallinckrodt (ACS 
grade, Phillipsburg, NJ, USA). MOPS was purchased from Alfa Aesar (Ward Hill, MA, 
USA). Deionized water was purified using ELGA Purelab Ultra (Lowell, MA, USA).  
Buffered solutions were prepared as described in Section 3.2.1. Standard stock solution of 
each sex steroid hormone was prepared and stored as described in Section 3.2.1. Stock 
samples were diluted to a desired concentration each d y prior to use with the proper 
buffer. The running electrolyte and the samples to be analyzed were prepared fresh every 
day prior to use. The sample buffer comprised of 1 mM CMCD, 5% methanol in 50 mM 
CAPS, pH 10. The running buffer comprised of 30 mM SDS, 13 mM HPCD in 200 mM 
phosphate, pH 2.5.  
4.2.2. INSTRUMENTATION 
All CE measurements were carried out using a Beckman Coulter P/ACE MDQ 
capillary electrophoresis instrument (Beckman coulter, Fullerton, CA, USA) equipped with 
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a photodiode array UV-visible absorbance detection system as described in Section 3.2.2. 
The separations were performed in a 25 µm id, 360 µm od, 30 cm long fused silica 
separation capillary (Polymicro Technologies, LLC, Phoenix, AZ, USA) with the detection 
window positioned 10.2 cm from the cathodic reservoir located at the sample inlet. The 
separations were conducted at 25 ± 1 ºC. To prevent th  disruption in the separation current 
during the electrophoresis all vials containing freshly made running buffers and samples 
were subject to vacuum degassing for short periods of time: 1 min for 1 mL vial or 15 sec 
for 250 µL vials. Ultrasonication was also used for this purpose when it was necessary. 
4.2.3. CE SEPARATION 
CE separations preceded by pH-stacking preconcentratio  were performed as 
described in Chapter 3, Section 3.2.5. Briefly, steroid standards prepared in 1 mM CMCD, 
5% methanol in 50 mM CAPS buffered at pH 10 were inj cted electrokinetically at 10 kV 
for 60 sec in silica fused capillary filled with the running buffer and containing the 
deionized water plug injected before the sample introduction at 13.8 kPa (2 psi) for 6 sec. 
The running buffer comprised of 30 mM SDS, 13 mM HPCD in 200 mM phosphate 
buffered to pH 2.5. Following the sample loading, the reverse polarity run at 16 kV was 
initiated to accomplish the separation of the steroids. 
4.2.4. FISH BLOOD/PLASMA SAMPLES 
All blood and plasma samples of the fish used in this work were generously 
provided by our colleagues Christy Foran, and Jennif r Stueckle from WVU Department 
of Biology; Kristine Willett of the University of Mississippi; Luke R. Iwanowicz and 
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Vicki S. Blazer from U.S. Geological Survey Leetown Science Center, Kearneysville, WV. 
Whole blood is a bodily fluid that flows through the eart, arteries, veins, and capillaries 
carrying nourishment, electrolytes, hormones, vitamins, antibodies, heat, and oxygen to the 
tissues of an organism. Blood contains red blood cells, white blood cells, and platelets 
suspended in fluid called plasma. Plasma is obtained by separating the liquid portion of 
blood from the cells and constitutes about 55 % of bl od volume. Plasma contains 90 % 
of water, the rest 10 % constitute albumin (the major protein 
constituent), fibrinogen (responsible for the clotting of blood), globulins, glucose, mineral 
ions, hormones and carbon dioxide. Frozen plasma is plasma frozen within hours after 
being collected in order to preserve clotting factors, stored for one to seven years, and 
thawed before used for research or medical purposes (30). 
4.2.5. PLASMA COLLECTION BY USGS 
Plasma collection was performed by Luke R. Iwanowicz of USGS, and is 
described briefly here. During early March 2008 yellow perch were collected from the 
Choptank or Severn Rivers (U.S. state of Maryland) during their spring spawning run. 
Fyke nets were deployed for fish capture and checked daily. Yellow perch were removed 
from the nets and transported to the US Fish & Wildlife Service, Chesapeake Bay Field 
Office (Annapolis, MD) for processing. Fish were maint ined at the USGS laboratory in 
aerated water from the collection site for transport and prior to plasma sample collection. 
The fish were euthanized with a lethal dose of tricaine methane sulphonate (Finquel MS-
222) (Argent Labs, Redmond, WA). The blood was drawn from the caudal vessels from 
each fish with a heparinized syringe, transferred to a heparinized vacutainer, and stored 
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on wet ice. The plasma was collected by centrifuging the vacutainers at 1000×g for 20 
min at 4 ºC. The plasma was removed and stored at –80 ºC in cryovials. While 
vitellogenin (an egg-yolk precursor protein) concentrations were not measured in 2008 
female fish, the fish collected during the same time in 2007 had measurable vitellogenin 
concentrations ranging from 2 – 10 mg/mL. 
4.2.6. PLASMA PRETREATMENT PROTOCOL # 1 
Ethyl acetate was employed to extract free steroid h rmones prior to CE separation 
as the first step of the plasma sample pretreatment. For this experiment the whole blood 
sample of the female wild catfish (Ictalurus punctatus) frozen for 6 years was used. The 
steroids were extracted from the blood using ethyl acetate similar to a procedure described 
in (22). Briefly, 250 µL (0.28 g) of thawed blood was extracted three times with 750 µL of 
ethyl acetate. This was accomplished by agitating the sample using a vortex mixer for 5 
sec, then spinning it for 5 min at 4,000 rpm and 4 ºC followed by the removal of the top 
organic fraction. The three ethyl acetate fractions were pooled, evaporated to dryness 
under the stream of nitrogen gas, and reconstituted in the sample buffer containing 1 mM 
CMCD, 5 % methanol in 50 mM CAPS buffered at pH 10. A flow chart of the extraction 
protocol with ethyl acetate is illustrated in Figure 4.1. The reconstituted extract was then 
preconcentrated using pH-stacking and analyzed by CE-UV-visible absorbance detection 




Figure 4.1. Flow chart of the plasma extraction protocol #1. 
4.2.7. PLASMA PRETREATMENT PROTOCOL #2 
The ethyl acetate extracts of fish plasma samples wre further purified by strong anion 
exchange extraction cartridges. In the experiment, a plasma sample from a single catfish 
was split into two fractions each at 412 µL in volume. Only one of the two fractions was 
spiked with 14 ng estradiol (50. pmol). Both fractions were then extracted three times 
with ethyl acetate (as described in Section 4.2.6). For each sample the three ethyl acetate 
fractions were pooled, evaporated to dryness under th  stream of nitrogen gas, and 
reconstituted in a solution comprised of 5% methanol, 95% aqueous 5mM MOPS 
buffered at pH 7.0. To facilitate the removal of the fatty acids collected in the extract, the 
solution was then loaded on a disposable quaternary amine (N+) strong anion exchange 
(SAX) cartridge (BAKERBOND speTM Quaternary Amine disposable extraction 
columns, J.T. Baker, Phillipsburg, NJ, USA) activated wice by consecutive washes with 6 
mL of methanol, 6 mL of water and 6 mL of 5 mM MOPS buffered at pH 7.0 (see Fig. 
4.2).  A quaternary amine is a strong base and exists as a positively-charged cation that 
exchanges or sequesters anionic species in the solution. It can therefore be used to isolate 
and discard them. The pKa of a bonded quaternary amine functional group is very high (> 
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14) and leaving it charged at all pHs when in contact with an aqueous solution. For an 
anionic compound of interest, the pH of the matrix must be 2 pH units above its pKa for it 
to be charged. Therefore, to extract fatty acids (pKa ~ 5) a buffer solution of pH 7 was 
used. Following introduction of the sample, the column was rinsed with 1 mL of solution 
comprised of 5 % methanol, 95 % aqueous 5 mM MOPS buffered at pH 7.0. The eluted 
fraction was evaporated to dryness using a rotary evaporator and reconstituted in 50 µL
of the solution comprised of 5 % methanol, 23 mM CMD, 50 mM CAPS buffered at pH 
10. The sample was preconcentrated and analyzed by CE as described in Section 3.2.5.  
 
Figure 4.2. Flow chart of the plasma extraction protocol #2. 
 
4.2.8. PLASMA PRETREATMENT PROTOCOL #3 
For this study plasma samples from bass and yellow perch were used. An aliquot 
of a thawed plasma sample was split in half. Only one half was spiked with a 
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gravimetrically determined amount of steroids, 2.7 ng of estradiol and 14 ng of 
testosterone. Each fraction was transferred into a separate borosilicate glass vial and 
extracted with the volume of ethyl acetate that is hree times larger than the sample 
volume. After adding ethyl acetate, the solution was mixed for 1 min using a vortex 
mixer and then centrifuged for 5 min at 10,000 rpm and 4 ºC.  The organic fraction was 
then removed. Extraction was repeated two more times, and three ethyl acetate extracts 
were pooled together and evaporated to dryness at room temperature using a Savant 
SpeedVac® concentrator. Each dry extract, spiked and unspiked, was reconstituted in the 
solution comprised of methanol: 5mM aqueous MOPS buffered at pH 7.0 (20:80, v/v). 
The solution was loaded on a quaternary amine disposable extraction column 
(BAKERBOND spe Quaternary Amine disposable extraction columns, J.T. Baker, 
Inc., Phillipsburg, NJ, USA) to remove fatty acids extracted with ethyl acetate. Before 
use, the ion exchange column was activated twice by consecutive washes with 6 mL of 
methanol, 6 mL of water and 6 mL of 5 mM MOPS buffered at pH 7.0. The column with 
the loaded sample was washed with 1 mL of methanol: 5 mM aqueous MOPS buffered at 
pH 7.0 (20:80, v/v). The eluted solution was then loaded onto a C18 extraction column 
(Supelco Discovery DSC-18 SPE tube bed, Sigma Aldrich, St. Louis, MO, USA), 
activated in advance twice with 5 mL of methanol and 5 mL of water. The column was 
then washed with 1 mL of water, and the retained stroids were eluted with 1 mL of 
methanol: water (75:25, v/v) solution. The eluted fraction was evaporated to dryness at 
room temperature using the SpeedVac® concentrator. The dry sample was finally 
reconstituted into 30 microliters of solution comprising 5 % methanol, 1 mM CMCD in 
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50 mM CAPS buffered at pH 10, and finally analyzed by pH-stacking MEKC (see Fig. 
4.3).  
 
Figure 4.3. Flow chart of the plasma extraction protocol #3 
4.2.9. RADIOIMMUNOASSAY PROCEDURE BY USGS 
Plasma samples from yellow perch were analyzed for the sex steroids 17β-estradiol 
(E2) and testosterone (T). All samples were quantified via radioimmunoassay (RIA) by 
Luke R. Iwanowicz of USGS. Estradiol antibodies (#244 anti-estradiol-6-BSA) were 
purchased from Gordon Niswender (Colorado State University, Fort Collins, CO).  
Testosterone antibodies (polyclonal anti-testosterone R156/7) were purchased from Coralie 
Munroe (UC School of Veterinary Medicine, Davis, CA). Extraction efficiencies were 
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determined for the sex steroids, and all assays were validated and optimized for yellow 
perch.  
Plasma samples were extracted twice in a ten-fold excess of diethyl ether prior to 
RIA. Plasma estradiol concentrations were determined using the RIA method of Sower and 
Schreck (31) with slight modifications. The samples and estradiol standards were 
solubilized in 200 µL of room temperature phosphate buffered saline gelatin (PG) buffer 
(0.1% knox gelatin in Dulbecco’s phosphate buffered saline).  100 µL of anti-estradiol 
antiserum was added to the samples, vortexed and incubated at room temperature for 30 
min. The same volume of PG buffer was added to tubes designated to determine non-
specific background and total counts per minute (CPM). Following incubation 100 µL of 
tritiated 17β-estradiol (5000 CPM in PG buffer) was added to all tubes, vortexed and 
incubated at room temperature for 60 min. Samples were immediately cooled in an ice bath 
for 30 min and 500 µL of ice-cold charcoal-dextran solution (0.63 % alkaline charcoal and 
0.4 % dextran in PG buffer) was added. Samples werevort xed, incubated on ice for 15 
min and centrifuged at 2200 × g for 20 min at 4oC. Supernatant was then decanted into 
scintillation vials containing 4 mL of OptiPhase HiSafe 2 scintillation fluid (Perkin Elmer, 
Waltham, MA, USA) and mixed well. Sample CPM were masured using a Tri Carb 
Liquid Scintilation Counter (Perkin Elmer, Waltham, MA, USA) and mean sample CPM 
was determined over an 8 minute integration time. All samples were run in duplicate and 
plasma estradiol values were interpolated from a standard curve. Plasma hormone 
concentrations were interpolated from the standard curve using curve fitting software 
(Prism 4.0, GraphPad Software Inc.). The same procedure was repeated on fresh plasma 
samples for the determination of testosterone using its specific antibody. 
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4.3. RESULTS AND DISCUSSION 
4.3.1. FOUR STEROIDS TARGETED FOR ANALYSIS 
This study focuses on four steroids referred to as “classical reproductive steroids” 
considered to be important members of the endocrine system functioning in teleost fish: 
estradiol, α,β-dihydroxyprogesterone, testosterone, and 11-ketotestosterone (Fig. 1.1). 
These four steroids were selected as targets for the analysis as their control can assist in the 
identification and study of the occurrence of intersex triggered by endocrine disruption and 
to monitor reproduction in fish species (32).  
The endogenous levels of 11-ketotestosterone, unlike those of testosterone, in the 
blood plasma of teleost fish are reported to be higher in males than in females (33-37). 
Although sexual development and behavior of the male species is commonly due to 
testosterone, the dominant androgen in male teleost is 11-ketotestosterone (26). 
Testosterone is also secreted by both sexes; however, t stosterone levels in the female fish 
plasma are elevated during the breading season and its concentration in most female 
samples is found to be comparable or higher than tht in the male fish plasma (35, 38). The 
concentrations of the female hormone estradiol are higher in female fish plasma. Estradiol 
is produced in the follicle of the developing oocyte while α,β-dihydroxyprogesterone is one 
of the key mediators for the final oocyte maturation (39). The molecular properties of the 
targeted steroids are summarized in Table 2.2.  
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4.3.2. OPTIMIZED CAPILLARY FLUSHES  
After the developed CE-method was first applied to the fish plasma extracts, the 
migration times of steroids became irreproducible from run to run and their detection 
signals decreased dramatically even in the standard samples. This stimulated a need in a 
new capillary flush protocol development. The poor reproducibility of the analysis of 
plasma samples was traced to nonspecific surface adsorption of the impurities extracted 
from the blood/plasma samples, and introduced into the separation capillary during the 
sample injection. One way to overcome this problem was to change the separation capillary 
daily. However, the frequent change of the capillary is not only costly and time consuming 
but also has a potential of introducing systematic measurement errors. Therefore the 
flushing protocol used to regenerate the inner surface of the separation capillary has been 
modified by replacing the methanol wash used in the morning described in Chapter 3 with 
1 N sodium hydroxide. Conditioning the separation capillary with a strong base actively 
regenerates the inner capillary surface by dissolving the silica substrate and therefore 
helps remove any compounds remaining in the capillary after the blood/plasma sample 
analysis (40).  
The recent work was conducted under the conditions of suppressed EOF when the 
charges of the silica surface were eliminated by the suppression of the dissociation of the 
surface silanol groups. The new capillary flush procedure, however, introduced a slight 
change in the steroid migration times. The new protocol for capillary flushes used at the 
beginning of each day included sequential timed flushes at 172 kPa (25 psi) for 15 min 
with 1N sodium hydroxide, 5 min water, 25 min 0.1 N hydrochloric acid, 5 min water, 25 
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min with running buffer. Running electrolyte was comprised of 30 mM SDS, 13 mM 
HPCD in 200 mM phosphate buffered at pH 2.5. In betwe n runs, the capillary was flushed 
at 172 kPa (25 psi) for 2 min with the running electrolyte.  Due to the change in the 
migration times for two of the previously analyzed steroids, estradiol and 11-
ketotestosterone, the linear range, the within-day and day-to-day reproducibility in peak 
area and migration time were determined with the new flush set. Two newly selected 
steroids, α,β−dihydroxyprogesterone and testosterone, were included in the method 
evaluation studies.   
4.3.3. METHOD SELECTIVITY  
The selectivity of the method for the four targeted steroids was assessed using a 
set of eight steroids mixed in a single sample. These eight steroids: α,β-
dihydroxyprogesterone, 17β-estradiol, estrone, ethynyl estradiol, hydroxyprogesterone, 
11-ketotestosterone, progesterone, and testosterone, were analyzed using stacking-
MEKC. All eight steroids were baseline separated anthe resulting electropherograms 
are represented in Figure 4.4. The representative background subtracted 
electropherograms are shown in Figure 4.5. The background subtraction was not used for 
the peak quantitation as it does not affect the reproducibility of steroid analysis.  
Interference from androstenedione was also studied. Androstenedione is a 
precursor of testosterone in the steroid biosynthesis pathway. A sample containing both 
steroids was analyzed at the stacking conditions. The resolution for both steroids was 
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Figure 4.4 illustrates the raw electropherograms obtained for 8 steroids simultaneously present in the 
analyzed sample. Data collected at 254 nm (top): (1) progesterone (500 nM); (2) α,β-dihydroxyprogesterone 
(500 nM); (3) hydroxyprogesterone (2 µM); (4) testosterone (1 µM); (6) 11-ketotestosterone (2 µM).Data 





Figure 4.5. Background subtracted electropherograms obtained for 8 steroids simultaneously present in the 
analyzed sample. Data collected at 254 nm (top): (1) progesterone (500 nM); (2) α,β-dihydroxyprogesterone 
(500 nM); (3) hydroxyprogesterone (2 µM); (4) testosterone (1 µM); (6) 11-ketotestosterone (2 µM). (B) Data 
collected at 200 nm (bottom): (5) estrone (500 nM); (7  ethynyl estradiol (250 nM); and (8) 17β-estradiol (250 





A separate study was conducted in order to determin the migration time for α,α- 
dihydroxyprogesterone, an isomer of α,β- dihydroxyprogesterone that can possibly be 
present in plasma (41, 42) and interfere with the separation. The results demonstrated that 
α,α- dihydroxyprogesterone co-migrated with progesteron  during the analysis (Fig. 4.7). 
Baseline resolution of these two hormones can be achieved by adjusting the SDS/HPCD 
ratio in the background electrolyte. However, both f them were baseline separated from 
α,β- dihydroxyprogesterone, which is typically present at much higher concentration levels 
in the fish plasma (41, 42). The electropherogram in Figure 4.7 shows the separation of the 
three steroids. Progesterone and α,α- dihydroxyprogesterone were not analyzed in this 
study because of their expected low concentrations in the fish plasma.  
 
 
Figure 4.6. Stacking electropherograms of (1) progesterone; (2) α,α-dihydroxyprogesterone; and (3) α,β-
dihydroxyprogesterone. Concentration of each is 500 nM. Data collected at 254 nm. 
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4.3.4. FIGURES OF MERIT OF MODIFIED METHOD 
The linear regression parameters for the calibration curves and all the figures of 
merit in this chapter were derived from the samples with four targeted steroids. The linear 
range for each steroid was determined from nine calibration curves (3 per day for 3 days).  
Curves were measured simultaneously for 4 analytes. The detection was performed by UV-
visible absorbance at detection wavelength of 254 nm for dihydroxyprogesterone (R2 ≥ 
0.990), testosterone (R2 ≥ 0.997), and ketotestosterone (R2 ≥ 0.995), or 200 nm for estradiol 
(R2 ≥ 0.996). The within-day and day-to-day reproducibility were measured at 1.0 µM 
dihydroxyprogesterone, testosterone, 11 ketotestosterone, and 0.50 µM estradiol. The 
within-day and day-to-day reproducibility of the migration time was ≤ 1 and ≤ 2 % RSD 
respectively for all four steroids. The corresponding values of the peak area ranged from 1 
to 6 % RSD and from 1 to 20 % RSD. The data are summarized in Table 4.1. 
   Reproducibility  
   Within day (n=10)   Day-to-day (n= 3) 
Steroid LOD  
(nM) 




Area (x103)   Time  
(min) 
Area (x103) 
        
α,β-Dihydroxy 
progesterone 
11 ± 3 0.20 - 5.0 2.45 ± 0.007 1.11 ± 0.06  2.43 ± 0.03 1.15 ± 0.06 
       
Testosterone 4 ± 1 0.10 - 14. 2.93 ± 0.01 3.19 ± 0.07  2.86 ± 0.07 3.5 ± 0.3 
11-Keto 
testosterone 
14 ± 3 0.50 - 10. 3.33 ± 0.02 1.05 ± 0.06  3.23 ± 0.04 1.0 ± 0.2 
       
17β-Estradiol 2.9 ± 0.6 0.050 - 5.0 3.88 ± 0.03 8.4 ± 0.1  3.82 ± 0.06 8.3 ± 0.1 
Table 4.1.  Stacking - MEKC Figures of Merit   
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4.3.5. DEVELOPMENT OF THE PLASMA SAMPLE PURIFICATION METHOD  
Blood plasma is a complex mixture and contains many compounds that can 
interfere with the analysis of steroids by stacking preconcentration. Therefore, the analysis 
of plasma samples by the developed method required a development of a thorough sample 
purification protocol. Many methods exist for biological samples purification, including the 
extraction with organic solvents and different combinations of solid phase extraction (43, 
44). Steroid hormones are present in plasma in the free (unconjugated) or conjugated form 
such as sulfated and glucuronidated conjugates. The free lipophilic steroids can be 
extracted from plasma using non-polar organic solvents. As mentioned earlier, 
immunoassay is widely used in biological laboratories to measure circulating steroid levels 
in fish. In immunoassay analysis the extraction of steroids from biological fluid samples is 
often accomplished using ethyl acetate or diethyl ether (22, 45). The organic solvent 
denatures carrier proteins releasing hormones such as estradiol and testosterone bound to 
SHBG with high affinity (46). Therefore the total concentration of the steroids, free and 
bound, can be determined while the hydrophilic sulfated and glucuronidated conjugates 
remain in the aqueous fraction (i.e. plasma) after ethyl acetate extraction has been 
performed.  
One of the biggest concerns in this extraction method is the potential to 
concentrate trace impurities from the extraction solvent. Therefore the blank extractions 
of deionized water employing 4.5 mL of reagent grade ethyl acetate and ACS grade ethyl 
acetate (99.5% purity) were first performed. The results demonstrated reagent grade ethyl 
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acetate contained a large number of interfering peaks comparing to the ACS grade ethyl 
acetate (99.5% purity) which was therefore used in further studies.  
Additionally, the other lipid constituents of blood, i.e. cholesterol and fatty acids, 
are also extracted in the organic phase. Cholesterol has very high affinity to CD cavities 
and competes with the steroids of interest forming strong inclusion complexes with CDs 
(47). The fatty acids in turn are anionic at the pH 10 owing to the presence of the 
carboxylic group and therefore are driven into the separation capillary along with the 
CMCD molecules carrying lipophilic compounds and therefore are preconcentrated at the 
pH-junction. Both types of compounds will interfere with the separation of the steroids by 
the developed stacking-MEKC and have to be eliminated. 
The limitation of the sample pretreatment using only ethyl acetate for stacking-
MEKC analysis is demonstrated in Figure 4.7. For this experiment the catfish fish plasma 
sample was pretreated with ethyl acetate as describd in methods Section 4.2.6. As seen 
in the Figure 4.7-A the electropherogram contains several highly intensive co-migrating 
peaks in the migration time interval from 0 to 2 min. The nature of these interfering peaks 
is caused by the compounds extracted in ethyl acetate th t either have very high affinity 
to the SDS micelles or are anionic and therefore migrate early driven by their anodic 
attraction. No steroids were detected in this sample. The electropherogram in Figure 4.7-
B was measured for the same reconstituted plasma extr ct but ten times diluted with the 
sample buffer. The dilution decreased the concentration and as a result the signal of the 
interfering compounds, however, no steroids were det ct d in the sample as confirmed in 
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the electropherogram C (Fig. 4.7) measured for the 10 times dilute extract spiked with 10 
µM ethynyl estradiol and estrone.  
 
Figure 4.7. The electropherograms obtained for the catfish blood extract. A – ethyl acetate extract reonstituted 
in 1 mM CMCD, 5% methanol, 50 mM CAPS, pH10. (* - unknown interference from blood, ? – steroid 
migration time window). B – extract, ten times dilute with the sample buffer;  C – extract, ten times diluted 
with the sample buffer, spiked with 10 µM ethynyl estradiol (EE) and estrone (E1). Stacking conditions are 
outlined in text.  
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In order to eliminate the presence of the charged fatty acids another blood sample 
was subject to extraction by anion exchange using disposable cartridges. The method was 
applied to the blood sample from male catfish frozen for 6 years. The plasma sample was 
pretreated prior to analysis as described in Section 4.2.7. The spiked portion of the plasma 
sample reconstituted in 1mM CMCD did not contain an analyte peak for estradiol in the 
electropherogram. This is likely due to the presence of neutral lipids, such as cholesterol, 
co-extracted in ethyl acetate, which solubilize the steroids so their association with CMCD 
is significantly reduced. This was prevented by increasing the concentration of CMCD in 
the sample to 23 mM, which provided more cyclodextrin available for capturing estradiol 
from the sample. However, standard solutions of steroid reconstituted in aqueous CMCD 
with the concentration greater than 1mM yield a lower detector response (Section 3.3.2.3). 
As a result, the determination of steroids in blood required the analyte quantification using 
a method of standard addition and increased concentratio  of CMCD. A three point 
standard addition curve was obtained for each sample (R2 ≥ 0.999) by analyzing the 
reconstituted sample as well as the reconstituted sample spiked successively with 6.0 ng of 
estradiol. Using this method, a concentration of estradiol in the unspiked blood sample was 
0.38 ± 0.04 µM that corresponds to 5.6 ± 0.6 ng in the sample analyzed, or in other words 
14 ± 1 ng/mL blood. The sample spiked with an additional 14 ng estradiol prior to 
extraction contains a concentration of 1.4 ± 0.1 µM, which corresponds to 21 ± 2 ng in the 
sample analyzed, equivalent to 110 % extraction recov ry. The advantage of the standard 
addition calibration method is a constant compositin of the matrix for all the samples. 
However, in this study a three point external standard calibration curve would be a better 
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option as it decreases the total analysis time, which is beneficial for high throughput sample 
screening. In addition, to properly carry out the standard addition method the sample has to 
be split in 4 equal volume fractions. An increasing volume of the steroid standard is added 
to each portion of the sample and then diluted to the same final volume with the sample 
buffer. In this work, the total volume of the reconstituted plasma extract was 30 microliters 
and further spiking and dilution of such small volume would be an error prone, therefore 
the standard addition was performed by repeatedly spiking the sample with the standard. In 
this case, the response was normalized to account fr he dilution factor, which was 
minimized by keeping the total volume change less than 5.5 %. However, in this case the 
same sample was analyzed subsequently for at least 4 times, after which it could not be 
used for further analysis if necessary. Therefore the critical steps in the sample preparation 
protocol needed to be changed in order to: (1) enhance overall steroid recovery while 
eliminating the interfering compounds extracted from plasma and (2) allow for a 3-point 
standard calibration curve instead of the standard addition. These led to the optimization of 
the sample preparation protocol by including a third and final extraction step in the 
extraction protocol. This extraction step utilizes a reversed phase C18 extraction column 
used to eliminate interference from neutral highly lipophilic substances, such as 
cholesterol, and was measured as described in Section 4.2.8. The steroids were eluted in the 
solvent containing 75% methanol and therefore could easily be dried out. The complete 
improved extraction scheme is outlined in Figure 4.3 and includes three stages: (1) 
extraction with organic solvent, ethyl acetate; (2) combination of (1) and a strong anion 




Most aquatic exposure studies require a reasonably l rge population for statistical 
significance, therefore there was the need for automa ed sample preparation and fast 
instrumental analysis to provide high sample throughput. For faster sample preparation in 
this study a vacuum box with twelve cartridge holders was used. Comparing to the gravity 
flow methods the use of the vacuum box offers more rapid flow rates by applying increased 
vacuum to each extraction cartridge holding a sample, therefore, the extraction proceeds 
with the same rate and twelve samples can be prepared simultaneously reducing the total 
analysis time. In commercial laboratories sample purification protocol can be accomplished 
using robotic systems which increase the speed of the sample preparation and the number 
of the samples purified up to 96 and more.  
 4.3.5.1. The Evaluation of the Steroid Elution from the SAX Cartridge  
Ethyl acetate extracts require reconstitution in aqueous buffer before loading them 
onto a SAX cartridge. Because steroids are lipophilic compounds they cannot be 
dissolved in aqueous solutions, therefore the addition of small amount of methanol to the 
dried out extract assisted steroid dissolution. Different percent concentrations of 
methanol in 5 mM aqueous MOPS buffered at pH 7.0 used for reconstitution of the dried 
ethyl acetate extracts before loading them onto SAX cartridge were tested. The methanol 
content was minimized to avoid the possible loss of teroids out of the extraction column, 
during sample loading. The concentrations tested were methanol: 5 mM MOPS (15:85, 
20:80, and 25:75, v/v). Aqueous samples containing 14 ng of testosterone were prepared 
and extracted as described in Section 4.2.7. The evaporated extracts were reconstituted in 
30 µl of the sample buffer containing 1 mM CMCD and analyzed by the stacking-MEKC 
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as described in Section 3.2.5. The solution comprised of methanol: 5 mM MOPS (20:80, 
v/v) resulted in 64% testosterone recovery. The further increase of methanol 
concentration did not improve the recovery, therefore, methanol: 5 mM MOPS (20:80, 
v/v) was used in the further studies.  
4.3.5.2. Recovery of Standard Steroids from C18 Cartridge  
The purpose of the present experiment was to determin  the amount of methanol 
required for elution of the targeted steroids from the C18 silica while leaving the highly 
lipophilic compounds such as cholesterol being retain d by C18 cartridge. The 
experiment was conducted using estradiol due to its high hydrophobicity (log P = 4.1) 
comparing to the other targeted steroids (Table 2.2). The optimal amount of the methanol 
used to collect the most of the estradiol from the cartridge should be sufficient to elute the 
rest of the targeted steroids as they are less hydrophobic and require more polar solvent. 
Each steroid sample comprised of 2.7 ng of estradiol prepared in 1 mL of methanol: 5 
mM MOPS (20:80, v/v) was loaded onto a pre-activated as described in Section 4.2.8 
C18 cartridge and then eluted with 1 mL of elution solvent comprising deionized water 
and different volume percent concentrations of methanol (25, 35, 45, 55, 65, 75, 85, 95, 
100, %v). The Figure 4.8 demonstrates the plot of estradiol percent recovery versus the 
amount of methanol used to elute the steroid from the C18 extraction cartridge. The 
elution solution containing methanol: water (75:25, v/v) was used in the further studies as 
it is just enough to give the highest recovery of estradiol (90 %) from the cartridge. The 
further increase in methanol content also resulted in a high recovery of estradiol. 
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However, it can cause the elution of highly lipophilic cholesterol form the C18 cartridge 




Figure 4.8. Plot of the estradiol recovery (%) versus the percent oncentration of methanol in water used to 





4.3.5.3. Stability Studies  
Two estradiol standards were compared in order to study the stability of steroids 
over the storage period. Two sets of four solutions f 1 µM estradiol samples prepared in 
the sample buffer were analyzed by stacking-CE. Thefirst set was prepared using the 
freshly made estradiol stock in methanol prepared fom a recently purchased powdered 
chemical. The second set was prepared out of the 1-y ar old solution of estradiol in 
methanol made using a solid estradiol stored for 6 years in dark at room temperature. The 
representative electropherograms are shown in Figure 4.9. The peak areas for the fresh 
estradiol set were (14.5 ± 0.1)×10
3 and for the old estradiol standard peak area was (14 ± 
1)×103  (n=4).  
 
Figure 4.9. Representative electropherograms for the steroid stability study. A – 1.0 µM estradiol prepared 
from fresh standard (peak area = 14.7 × 10
3), B – 1.0 µM estradiol prepared from the aged standard (peak 
area = 15.7 × 10
3). Samples were prepared in the sample buffer containi g CMCD and subject to stacking-
CE analysis as described in the text. 
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The signals measured for both estradiol sample sets demonstrated no statistical 
difference which suggests that if the steroid stock is stored properly (in case of the solid 
reagent – in a dark dry place at room temperature, and in case of the methanol stock 
solution – in a dark dry place at – 20 ºC) degradation is less than 4 % during the storage 
period. However, it was important to eliminate the loss of the steroids due to photo- or 
thermal degradation during the sample preparation pr cedure, which consists of several 
steps including extraction, evaporation and sample reconstitution. The corresponding 
study is discusses in the following section. 
4.3.5.4. Effect of Temperature During Dry Down on the Recoveries 
Although the literature reports consider the photo-degradation to be the primary 
reason for the decomposition of testosterone (48-50) (the kinetics of the photo-degradation 
was not studied in this research), the experimental studies in this research demonstrated that 
testosterone is partially decomposed under the influe ce of the heat. In the early 
experiments for the steroid recoveries a rotary evaporator was used for the gentle removal 
of the solvents form the sample solutions before reconstituting them in the sample buffer 
containing CMCD. The rotary evaporator device includes a condenser, a temperature 
controlled water bath for the sample heating, and a vacuum system for the vapor being 
drawn off of the sample. The samples to be evaporated where placed in clear glass vials but 
to prevent exposure to ambient light the rotary evapor tor was covered with the layers of 
aluminum foil. To speed up the evaporation process of aqueous samples of > 2 mL the 
temperature of the water bath was increased to 50 ºC. The highest percent recovery of 
testosterone prepared using this evaporation system was only 64 %. An alternative 
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experiment was conducted using a SpeedVac ® concentrator device that evaporates 
samples containing water at room temperature. Testost rone samples covered to prevent 
their exposure to the ambient light were evaporated at 20 ºC and the recovery of 
testosterone pretreated this way was 93 %. Based on this the dry down of the samples 
extracts was further carried out at the room temperature using SpeedVac® concentrator.  
4.3.5.5. Recovery of Standard Steroids from Aqueous Solutions 
The sample extraction steps were studied using aqueous standards as well as fish 
plasma samples. Prior to estimating total recovery, the recovery of estradiol and 
testosterone at each step of the optimized extraction scheme (Fig. 4.3) were measured 
using aqueous solutions of both steroids. The recovry study was performed by taking a 
sample of deionized water, splitting it in half. Only one half was prepared by adding a 
desired amount of steroids (2.7 ng of estradiol and14 ng of testosterone) to deionized 
water with 5% of methanol present to avoid steroid precipitation. Each sample was 
extracted with ethyl acetate as described above in Section 4.2.6, evaporated to dryness, 
reconstituted in CMCD matrix and subjected to CE separation. The recoveries of 
estradiol and testosterone, extracted in ethyl acetate were 106 % of each. Then the 
recoveries for testosterone and estradiol from extraction columns were measured. The 
aqueous sample of testosterone and estradiol was loaded on a quaternary amine SAX 
cartridge, followed by C18 cartridge application. Three elution fractions were collected, 
fraction 1 and 2 were 1 mL of methanol: water (75:25, v/v) each, and fraction 3 was 100 
% methanol. The highest recovered concentration of steroids was measured only in the 
first fraction, 91 % recovery for estradiol and 84 % recovery for testosterone. No spiked 
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steroids were found in fractions 2 and 3. The results are summarized in Table 4.2. The 
advantage of these elution techniques is a high recovery of steroids from the extraction 
columns in a small volume of the solvent (1 mL), while leaving highly lipophilic 
substances, which require less polar solvent for elution, strongly retained on C18 
material. 
 Table 4.2. Recovery of standard 17β-estradiol and testosterone from aqueous solutions. 
Steroid Spiked  Recovered  
 ng  ng  %  
       
17 β-estradiol       
 
EA extraction 2.7  2.9 ± 0.6  106  
(N+) SAX + RP C18 fraction 1 2.7  2.5 ± 0.2  91  
       
Testosterone        
 
EA extraction 14  15 ± 3  106  
(N+) SAX + RP C18 fraction 1 14  12 ± 2  84  
       
EA = ethyl acetate 
SAX = strong anion exchange cartridge 




4.3.5.6. Steroid Recovery from Fish Plasma 
To determine whether the biological origin of the fish species can affect the steroid 
analysis using the optimized procedure, four different fish species: catfish (Ictalurus 
punctatus), smallmouth bass (Micropterus dolomieu), largemouth bass (Micropterus 
salmoides), and yellow perch (Perca flavescens) were used for investigation. Each blood or 
blood plasma sample was split in half. One half wasunspiked and analyzed to measure the 
endogenous steroids. The other half of the plasma sample was spiked with 2.7 ng of 
estradiol and 14 ng of testosterone and was used to measure the recovery of steroids 
comparing to the unspiked sample. The sample pretreatment and sample analysis were 
performed similar to the method described in Section 4.2.8. Briefly, each sample was 
extracted with ethyl acetate, evaporated to dryness, r constituted in MOPS, loaded on a 
quaternary amine SAX cartridge, followed by C18 cartridge purification. The first 1 mL of 
methanol: water (75:25, v/v) was collected, evaporated to dryness, reconstituted in CMCD 
buffer and analyzed by CE as described in 3.2.5. A schematic flow-chart for sample 
pretreatment is illustrated in Figure 4.10.  
 
Figure 4.10. Steroid recovery from fish plasma. Flow chart of the plasma sample preparation. 
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The results are summarized in Table 4.3. All the concentrations were measured 
using a three-point external standard calibration curve. The estradiol recovery ranged from 
74 % in catfish blood to 85 % in yellow perch plasm, and testosterone recovery ranged 
from 77 % in catfish blood to 102 % in largemouth bass (R2 ≥ 0.98). Figure 4.11 illustrates 
representative electropherograms of estradiol and testosterone recovery from a catfish 
blood sample. After running the sample by CE, it was spiked with additional amounts of 
targeted steroid and reanalyzed. The increase of the peak at a specific migration time for 
each added steroid confirmed the presence of the steroid in the sample. 
Table 4.3. Recovery of standard steroids from fish plasma. 
 
Steroid   Sample 
volume 
 Spiked  Recovered   Linear regression data parameters 
   µl  ng  ng %  Slope   Intercept 
(×103) 
 R2 
17β-estradiol              
Catfish*  120  2.7  2.0 ± 0.2 74  19 ± 1  -0.1 ± 0.1  0.998 
Smallmouth bass  100  2.7  2.1 ± 0.05 78  14 ± 0.3  0.1 ± 0.05  1.000 
Yellow perch  100  2.7  2.3 ± 0.6 85  17 ± 1  -0.2 ± 0.3  0.997 
              
Testosterone               
Catfish*  120  14  11 ± 1 77  3.4 ± 0.2  0.02 ± 0.1  0.997 
Smallmouth bass  100  14  13.3 ± 0.2 94  3.1 ± 0.02  0.1 ± 0.01  1.000 
Largemouth bass  100  14  14.5 ± 0.2 102  3.1 ± 0.02  0.1 ± 0.01  1.000 
Yellow perch  100  14  12 ± 3 84  2.6 ± 0.4  0.08 ± 0.2  0.982 
 





Figure 4.11. Steroid recovery data from a single catfish blood sample. Lower trace in A and B is the 
electropherogram obtained for the unspiked catfish blood extract. Top trace in A and B is catfish blood spiked 
with 14 ng of testosterone and 2.7 ng of 17β-estradiol prior to extraction. In A, * is recovered stradiol; in B, * 
is recovered testosterone. 




In teleost fish 11-ketotestosterone is important for sexual differentiation and male 
sexual development (51, 52) and is a mediator of altered cellular function and 
differentiation, which makes steroid availability susceptible to environmental signals. 
While performing the measurement of the steroids in the fish plasma it was noticed that 
the levels of 11-ketotestosterone were much higher comparing to the results reported in 
the literature. Although both testosterone and 11-ketotestosterone strongly absorb light at 
the 254 nm wavelength they also produce low detection response at 200 nm as 
demonstrated in Figure 4.12-A. The intensity of the peak corresponding to the migration 
time of testosterone in the reconstituted fish plasm  did not deviate from the effect 
observed for a standard steroid mixture, however, th  opposite was observed for the peak 
corresponding to the migration time of ketotestosteron  (Fig. 4.12-B). The intensity of 
this peak was much higher at 200 nm than at 254 nm thus suggesting the presence of an 
interfering compound which migrates at the same time as 11-ketotetsosterone. 11-
ketotestosterone was not quantified in the following fish studies as it requires mass-
spectrometry detection in order to evaluate the nature of the interference and eliminate its 





Figure 4.12. The electropherograms representing the analysis of a sample containing standard T, 11 KT, 
and E2 (A), and yellow perch plasma extract (B). Electropherograms shown in solid are measured at 200 
nm, electropherograms represented in dotted lines are measured at 254 nm.  Standard sample contained 250 
nM of estradiol, 550 nM testosterone and 2µM 11 ketotestosterone. Standard samples were prepared in 1 
mM CMCD, 5% methanol in 50 mM CAPS buffered at pH 10. The blood extract was reconstituted in the 
same sample buffer. The separation conditions are outlined in the text.  
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4.3.5.7. Calibration Method and Effect of Plasma Volume on Stacking 
The results obtained with the use of a three point external standard calibration 
curve were compared to the results measured with a three point standard addition method. 
The effect of the plasma sample volume on the analysis of steroids by the stacking-
method was studied as plasma volume can cause the variance in steroid recovery because 
the amount of extracted steroids as well as the interfering compounds increases with the 
increased plasma volume. A plasma sample from a single yellow perch fish was used for 
this experiment. A 100 µL plasma volume was subjected to extraction with ethyl acetate 
and two solid-phase extraction columns as described in Section 4.2.8. An endogenous 
concentration of testosterone measured using a three point standard calibration curve was 
equal to 12.6 ± 0.1 ng/mL plasma (R
2 = 1.000). By means of a standard addition method 
11 ± 1 ng of testosterone was measured per 1 mL of plasma (R2 = 0.990). As a standard 
addition curve the sample was sequentially spiked with 0.85 ng of testosterone. Figure 
4.13 is a representative example of a three point standard addition method used for 
analysis a yellow perch blood plasma sample. The results obtained by both calibration 
methods demonstrated close values, based on what, a 3-point standard calibration curve 
was further used for all the measurements. 
In order to investigate how the volume of plasma taken for analysis affects the 
recovery of steroids the higher amount of the same plasma sample was extracted. The 
endogenous concentration of testosterone analyzed in 200 µL of the same yellow perch 
plasma sample was found to be 13.5 ± 0.3 ng/mL of plasma (R
2 = 1.000). Thus, the 
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extraction procedure combined with stacking-CE analysis was not limited by a plasma 
sample volume.  
 
Figure 4.13. Illustrative stacking electropherograms obtained by the method of standard addition for a blood 
plasma sample from a single yellow perch fish.  Thelower trace is unspiked plasma sample. A three point 
standard addition curve (R2 = 0.990) was obtained by repeatedly spiking the plasma extract with 0.85 ng of 
testosterone. Peak labeled T is testosterone.  
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4.3.6. METHOD APPLICATION TO THE STEROID ANALYSIS IN YELLOW PERCH  
The stacking-MEKC method was applied to the analysis of a larger set of yellow 
perch fish provided by the researchers from USGS who ere interested in studying the 
possibility of endocrine disruption in yellow perch. Yellow perch (Perca flavescens) are a 
valued resource in the Chesapeake Bay watershed and the Great Lakes as they are 
exploited commercially and recreationally. Historically, yellow perch in the Chesapeake 
Bay have supported a major commercial fishery, as well.  However, the harvest declined 
from over one million pounds per year around 1900 to 66,000 pounds in 1990 (53). 
Landings rebounded to nearly 300,000 pounds by 2002, driven primarily by catches in 
the Head-of-Bay region (54).  In 1989, these population declines led to commercial and 
recreational closures (54).  While some rivers have reopened their recreation l fishery, 
several suburbanized tributaries (Severn, Magothy, South, and West Rivers) have not. 
 One operational hypothesis for the decline of yellow perch in these rivers was that urban 
growth and development near the watersheds reduced th  water quality, thereby 
decreasing recruitment success (55). Poor yellow recruitment has been observed in the 
Severn River, while stocks remain rather health in the Choptank River.    
In the method application study eleven fish plasma amples were analyzed by pH-
stacking MEKC. The fish samples were collected by the USGS researchers from two 
different sites: Severn River and Choptank River, sacrificed and processed for plasma 
samples as described in Section 4.2.5. The reproductive characteristics of the yellow perch 
fish used in this research have been studied by different fish biologists for several years 
(56-61). The plasma levels of estradiol, testosterone, 11-ketotestosterone and 
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dihydroxyprogesterone in male and female yellow perch are summarized in Table 4.4. For 
female fish the concentration range for steroids in plasma are: 0.1 – 5 ng/mL estradiol; 0.1 - 
30 ng/mL testosterone; 0.1 – 2 ng/mL dihydroxyprogesterone. In the male fish the reported 
levels of the steroids in plasma are: 0.2 – 8 ng/mL 11-ketotestosterone range; 0.1 – 8 
ng/mL testosterone; 0.01 – 0.02 ng/mL estradiol. All the values reported in the literature 
were determined by radioimmunoassay.  
Table 4.4. Levels of plasma steroids in yellow perch fish measured by RIA reported in the literature. 
Female yellow perch Male yellow perch Ref. 
E2,  ng/mL  T, ng/mL  DHP, ng/mL  11KT, ng/mL  T, ng/mL  E2, ng/mL  
0.4 ± 0.1 to  
3.0 ± 0.3 (fall);  
0.2 ± 0.1to  
2.5 ± 0.5 
(winter) 
2.0 ± 0.5 to  
3.0 ± 0.5 (fall); 
2.0 ± 0.5 to  
8 ± 3 (winter) 
Not reported 
2.0 ± 0.5 to  
4.0 ± 0.5 (fall); 
2.0 ± 0.5 to  
7 ± 2 (winter) 
2.5 ± 0.5 to  
6.0 ± 0.5 (fall); 
2.0 ± 0.2 to  
8 ± 4 (winter) 
Not reported 56 
Not reported Not reported Not reported 
0.20 ± 0.05  
to 0.6 ± 0.3 
0.1 to 4.3 0.01 to 0.02 57 
0.087 to 0.155 0.469 to 0.793 Not reported 0.523 to 0.881 0.856 to 1.035 Not reported 58 
0.08 ± 0.05 to 
5.13 ± 1.42 
0.1 to 30  Not reported Not reported Not reported Not reported 59 
0.1 to 3 ± 1 0.1 to 7 ± 1 0.1 to 2.0 ± 0.5 8.0 ± 1.2 2.8 ± 0.8 Not reported 60 
       
If 200 µL of blood is collected from each fish, extracted and reconstituted in a 
sample volume suitable for automated CE measurements (30 µL) the endogenous 
concentrations of steroids in this sample are expected to be for the female fish: 2.5 - 120 
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nM estradiol; 2.3 – 690 nM testosterone; 2.0 - 40 nM dihydroxyprogesterone. In male fish 
samples these concentrations will be: 4.4 – 180 nM 11-ketotestosterone; 2.3 – 190 nM 
testosterone; 0.25 - 0.50 nM estradiol. The limits of detection of the developed method are 
reported in Table 4.1 and are 2.9 ± 0.6 nM estradiol, 4 ± 1 nM testosterone, 11 ± 3 nM 
dihydroxyprogesterone and 14 ± 3 nM 11-ketotestosterone. The linear range of the method 
is 0.050 - 5.0 µL estradiol, 0.10 – 14 µL testosterone, 0.20 - 5.0 µL dihydroxyprogesterone, 
and 0.50 – 10. µL 11-ketotestosterone. Due to the low concentrations f the endogenous 
steroids in fish only major steroids were quantified n this work. The results for steroids 
measured in yellow perch by stacking-CE are summarized n Table 4.5. The results are 
obtained from a three point external calibration curve. Because of the limited plasma 
volumes available for this study, the obtained values were based on a single analysis for 
each yellow perch sample. Each analyzed plasma volume was 200 µl except for SE 21, 
which was 250 µl. As seen from the data the concentrations of steroids measured by the 
developed method were at the higher range of the exp cted levels reported in the literature.  
151 
 




























(ng/mL plasma) (ng/mL 
plasma) 
(ng/mL plasma) (ng/mL 
plasma) 
 1 2  1 2  
SE 21 F 28.28 ± 0.04 25.16   26.67 1.5 ± 0.4 1.35  1.21  - 
SE 24 F 13.5 ± 0.3 10.91   11.73   
      
- 0.97  0.93  16 ± 7 
16 ± 6 SE 25 M 30.5 ± 0.7 29.28   26.64   
      
- 0.264  0.203  
SE 26 F 43.9 ± 0.9 41.59  39.6     
    
- 0.997  0.924  5 ± 7 
SE 28 F 1.3 ± 0.9 2.68  1.91 - 0.688  0.725  34 ± 6 
SE 29 M 9.3 ± 0.8 7.34  7.82     
    
- 0.277  0.31  11 ± 7 
SE 32 M 15.5 ± 0.5 13.55  12.94 1.3 ± 0.3 0.248  0.281  - 
        
CH 23 F 0.9 ± 0.6 0.986  1.0       1.7 ± 0.8 1.44  1.62  - 
CH 24 M 4.8 ± 0.6 4.69  4.74     
    
- 0.294  0.221  - 
CH 27 F 20 ± 2 27.22  28.38   
      
- 0.993  1.07  19 ± 8 
CH 36 M ND 30.52  27.8      1.28 ± 0.05 0.281  0.392  - 
 
a Results are obtained using a 3 point external calibration curve (n = 1). Each analyzed plasma volume was
200 µl except for SE 21 which was 250 µl. b SE - Severn River; CH - Choptank River; ND – not determined; 
and ( – ) – below lowest standard, not quantified. 
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4.3.7. METHOD COMPARISON TO COMMERCIALLY AVAILABLE TECHNIQUES 
There are two ways to evaluate the accuracy of the developed method: (1) by 
performing the recovery studies of the steroid-free plasma that is spiked with 
gravimetrically determined amounts of a steroid and (2) by comparison to the 
measurements obtained by an independent method. In biomedical laboratories steroid 
hormones are frequently quantified by immunoassay technique (Section 1.2.3). Most of the 
immunoassays used are commercially available kits, which contain all the reagents 
required to perform an instrumental measurement of steroids in biological samples. 
However, a few publications reported a need for more thorough validation of the 
commercial immunoassay kits prior to use (62-65). The lack of specificity and the need of 
a different assay for each steroid are the major prblems associated with immunoassays 
for the steroids. Taieb and co-workers (66) conducted a study in which they compared ten 
different commercially available immunoassay kits with isotope-dilution GC-MS for 
analysis of testosterone in sera of 116 men, women and children. They concluded that 
none of the immunoassays tested were fully reliable for analysis of testosterone. Seven 
immunoassays demonstrated systematic 46% overestimation and the other three showed 
systematic 12% underestimation of the testosterone lev ls compared to the results 
obtained by the isotope dilution GC-MS. The possible reasons for the poor agreement 
between the results obtained by the two methods were: (1) matrix effect; (2) cross-
reactivity of the antibody with structurally similar steroids and metabolites; (3) the limit of 
detection and sensitivity of the immunoassay.  Other reports suggested the measurement of 
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plasma testosterone by current commercially available immunoassay is also a matter of 
concern for similar reasons (67, 68).  
Isotope-dilution GC-MS, another reference method (Section 1.2.2) requires 
expensive isotope standards and in order to be applied for method comparison in our lab, 
the method had to be developed and optimized with respect to the fish plasma sample 
matrix. In order to save time an attempt to find contract laboratory groups who had 
validated the isotope-dilution GC-MS method in-house and would be interested to analyze 
a few fish plasma samples prepared by our method for the presence of targeted steroids and 
method comparison. Due to difficulty locating any commercial laboratories capable of 
isotope-dilution GC-MS analyses of steroids a few laboratories which analyzed steroids by 
isotope-dilution LC-MS/MS were contacted. It was shown previously that isotope-dilution 
LC-MS/MS demonstrates the same accuracy for steroid analysis as isotope dilution GC-
MS (69-71) and is more popular in the clinical laboratories. Several contract laboratories 
have been contacted (72, personal communication by L. Bykova); however, most indicated 
concern that their methods have not been validated for the fish plasma matrices. Therefore, 
the developed method was evaluated by performing the recovery studies and by 
comparison to immunoassay which was available from the USGS collaboration group.   
As expected some steroids were below the limit of detection, some fell into the 
expected concentration range, while some steroids were detected at higher concentrations 
than expected. The results were compared to radioimmunoassay as described in Section 
4.2.9. The 80 % of the results measured by stacking-CE were close to and deviated by no 
more than 20 % from the results measured by radioimmunoassay. Testosterone was not 
detected by the stacking method in the sample CH 36 due to a shift in the baseline of the 
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electropherogram caused by unknown reasons that interfered with the detection of the 
testosterone peak. The levels of estradiol in SE 32 and CH 36 exceeded the results reported 
by radioimmunoassay by > 74% and could be due to the fact that the peak areas for 
estradiol measured by stacking-CE corresponded to the concentrations at the very low 
region of the calibration curve where larger standard deviations were observed. The 
concentration of estradiol in samples SE 24-26, 28, 29 and CH 24, 27 was not quantified 
because the peak areas for estradiol corresponded to the concentrations below the lowest 
steroid standard in the calibration curve. Dihydroxyprogesterone, in turn, was not measured 
by radioimmunoassay and, therefore, could not be compared to stacking-CE. However, the 
presence of dihydroxyprogesterone was determined in the female plasma samples SE 24, 
26, 28, and CH 27 as well as in two male plasma samples SE 25, and 29 by stacking-CE.   
4.3.8. FISH INSIGHT  
While in males the levels of 11-ketotestosterone and testosterone remain constant 
throughout the year, the high levels of testosteron in female fish are due to the fact that no 
estradiol needs to be produced after the vitellogenesis (formation of the yolk of an egg) in 
the females (17). Because the yellow perch in this study were captured during their 
spawning which occurs after the vitellogenesis the high levels of testosterone in the female 
fish (see Table 4.5) are not surprising. The presence of dihydroxyprogesterone in female 
samples SE 24, 26, 28, and CH 27 suggests the presence of the developing oocytes in these 
fish species, while the presence of dihydroxyprogesterone in two male plasma samples, SE 
25 and 29, is alarming because it can be associated wi h the presence of the developing 
eggs in the males. Both, SE 25 and 29, samples werecollected from the Severn River 
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where the recruitment of the yellow perch population has been decreasing over the past few 
years due to the water pollution caused by the rapid urbanization of the surrounding areas 
(55). Ethynyl estradiol, a component of the birth contr l pills and a potential EDC, was not 
found in the fish plasma samples.  The data for 11-ketotestosterone is not included (Table 
4.5) as it co-migrates with an unknown interference and thus requires a mass-spectrometry 
analysis in order to determine it. 
CONCLUSIONS AND FUTURE DIRECTIONS  
Chapter 4 demonstrated the development of a three step extraction protocol for the 
plasma pretreatment prior to the stacking-MEKC analysis which was validated using the 
aqueous steroid samples and the extracts of the plasma from four different fish species. The 
optimized extraction protocol followed by pH-stacking-MEKC method was applied to the 
analysis of steroids in the plasma of yellow perch and the obtained results were validated 
by immunoassay. The method showed good promise for the analysis of steroids in plasma 
samples.  
In future studies, the method can be applied to other fish species, wild or lab 
maintained. The lab maintained fish, for example Japanese medaka, is widely used in 
biological studies due to their ability to reproduce in the lab and the short period of the 
development of sexual differentiation, which is extr mely important for monitoring 
endocrine disruption. The small size of the fish allows for the statistical description of a 
large fish population. Using robotic systems available in many pharmaceutical laboratories, 
it is possible to multiplex the set of the samples prepared for analysis simultaneously to a 
156 
 
minimum of 96 samples. Therefore the total sample preparation time will be considerably 
decreased. 
Additional studies may include the analysis of the steroid conjugates circulating in 
the plasma, glucuronides and sulfates. Plasma samples can be treated by enzymes for 
hydrolysis of the steroid conjugates. Simultaneous analysis of all the sample constituents is 
important because it is desirable to determine not o ly the targeted steroids but also any 
interfering compounds or unexpected steroid metabolites which may appear as a result of 
the fish exposure to the EDCs. CE-MS can be used for structural elucidation of those 
steroids and conjugated steroids for which no standards are available.  
The method can be incorporated on a microchip to create a portable device that can 
be used for the field studies. This device will eliminate the need of collecting fish plasma 
samples and sending them over to chemistry laboratories for profiling steroids in fish 
samples.  
Finally the method can be applied for analysis of steroids in human plasma. In this 
dissertation research the developed method was applied to the analysis of a human serum 
certified reference material with a known content of estradiol. Human serum (17β-
estradiol, high level) certified reference material w s purchased from RT-Corp (Laramie, 
WY). The sample was certified by BCR (Community Bureau of Reference, the former 
reference materials program of the European Commission). A certified concentration of 
17β-estradiol present in human serum standard was 1.34 ± 0.07 nmol/L measured by 
isotope dilution GC-MS. The method used different isotopic labeled internal standards and 
chromatographic columns, following extraction with CH2Cl2 and clean-up by solid-phase 
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extraction. The standard was reconstituted following structions in the certificate of 
analysis. However, the obtained results for the estradiol concentration measured in human 
serum standard were inconclusive because of the sample atrix effect. This was expected 
to occur as the composition of human serum differs rom the composition of fish plasma 
and the levels of endogenous steroids in fish are higher than those in humans. Therefore the 
analysis of human biological fluids requires a reconsideration of the plasma/serum 
pretreatment scheme prior to the use of the stacking-CE analysis.  
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